Peter Goadsby

Q: What Schools Are Affiliated With Peter Goadsby

Peter Goadsby is affiliated with the following schools: University of New South Wales, University of California, Los Angeles, University of California, San Francisco, King's College London, King's College, Aberdeen

Peter Goadsby's AcademicInfluence.com Rankings

Peter Goadsby

Biology

#1471

World Rank

#2463

Historical Rank

Neuroscience

#100

World Rank

#107

Historical Rank

biology Degrees

Peter Goadsby

Philosophy

#1568

World Rank

#2817

Historical Rank

Logic

#240

World Rank

#506

Historical Rank

philosophy Degrees

Download Badge

Biology
Philosophy

Why Is Peter Goadsby Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Peter Goadsby FRS FRACP FRCP is an Australian neuroscientist who is Director of the National Institute for Health Research - Wellcome Trust King’s Clinical Research Facility and Professor of Neurology at King's College London. His research has focused particularly on the mechanism and alleviation of migraine and cluster headaches.

(See a Problem?)

Peter Goadsby's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The International Classification of Headache Disorders: 2nd edition (2003) (5261)
A Report on the Journal 2004 (2004) (2330)
Migraine--current understanding and treatment. (2002) (1752)
Vasoactive peptide release in the extracerebral circulation of humans during migraine headache (1990) (1397)
Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. (2004) (1070)
Hypothalamic activation in cluster headache attacks (1998) (1067)
The trigeminovascular system and migraine: Studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats (1993) (1048)
Pathophysiology of Migraine: A Disorder of Sensory Processing. (2017) (982)
Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials (2001) (874)
Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system (1988) (798)
A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. (1997) (738)
New Appendix Criteria Open for a Broader Concept of Chronic Migraine (2006) (711)
Guidelines for Controlled Trials of Drugs in Migraine: Second Edition (2000) (643)
Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. (1994) (619)
Brainstem activation specific to migraine headache (2001) (578)
EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force (2009) (574)
A Controlled Trial of Erenumab for Episodic Migraine (2017) (557)
The Trigeminovascular System in Humans: Pathophysiologic Implications for Primary Headache Syndromes of the Neural Influences on the Cerebral Circulation (1999) (545)
Triptans (Serotonin, 5-HT1B/1D Agonists) in Migraine: Detailed Results and Methods of A Meta-Analysis of 53 Trials (2002) (541)
Correlation between structural and functional changes in brain in an idiopathic headache syndrome (1999) (538)
Topiramate Reduces Headache Days in Chronic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study (2007) (503)
Pathophysiology of migraine (2006) (501)
Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. (2004) (489)
The International Classification of Headache Disorders, 2nd Edition (ICHD-II)—-Revision of Criteria for 8.2 Medication-Overuse Headache (2005) (485)
Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS) (2011) (476)
Cluster headache: A prospective clinical study with diagnostic implications (2002) (474)
Fremanezumab for the Preventive Treatment of Chronic Migraine (2017) (460)
Diencephalic and brainstem mechanisms in migraine (2011) (439)
A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. (2004) (424)
CGRP and its receptors provide new insights into migraine pathophysiology (2010) (421)
Premonitory symptoms in migraine (2003) (405)
Pathophysiology of cluster headache: a trigeminal autonomic cephalgia (2002) (402)
Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input. (2002) (402)
EFNS guidelines on the treatment of cluster headache and other trigeminal‐autonomic cephalalgias (2006) (390)
Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study (2011) (381)
A positron emission tomographic study in spontaneous migraine. (2005) (378)
Increased responses in trigeminocervical nociceptive neurons to cervical input after stimulation of the dura mater. (2003) (369)
Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial (2010) (363)
Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks. (2014) (359)
Greater occipital nerve injection in primary headache syndromes – prolonged effects from a single injection (2006) (351)
Ergotamine in the acute treatment of migraine: a review and European consensus. (2000) (343)
Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial (2018) (330)
Treatment of medically intractable cluster headache by occipital nerve stimulation: long-term follow-up of eight patients (2007) (314)
Functional magnetic resonance imaging in spontaneous attacks of SUNCT: Short‐lasting neuralgiform headache with conjunctival injection and tearing (1999) (313)
The clinical characteristics of headache in patients with pituitary tumours. (2005) (307)
Central nervous system mechanisms of pain (2002) (306)
PET and MRA findings in cluster headache and MRA in experimental pain (2000) (302)
Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study (2014) (293)
Consensus Statement: Cardiovascular Safety Profile of Triptans (5‐HT1B/1D Agonists) in the Acute Treatment of Migraine (2004) (292)
Calcitonin gene‐related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat (2004) (289)
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial (2014) (282)
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial (2016) (278)
Recent advances in understanding migraine mechanisms, molecules and therapeutics. (2007) (275)
Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area (2004) (259)
Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study (2018) (258)
Does Chronic Daily Headache Arise De Novo in Association With Regular Use of Analgesics? (2003) (256)
Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS) (2012) (249)
The periaqueductal grey matter modulates trigeminovascular input: a role in migraine? 1 1 Presented in part at the Xth International Headache Congress, Barcelona, Spain, 24–26 June 1999 [Knight and Goadsby, Cephalalgia 19 (1999) 315]. (2001) (247)
EFNS guideline on the drug treatment of migraine – report of an EFNS task force (2006) (247)
Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat (1993) (241)
Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine (2011) (238)
Posterior Hypothalamic and Brainstem Activation in Hemicrania Continua (2004) (236)
The trigeminocervical complex and migraine: Current concepts and synthesis (2003) (233)
High-flow oxygen for treatment of cluster headache: a randomized trial. (2009) (228)
Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides (1990) (223)
Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention (2014) (220)
The distribution of trigeminovascular afferents in the nonhuman primate brain Macaca nemestrina: a c‐fos immunocytochemical study (1997) (217)
Treatment of intractable chronic cluster headache by occipital nerve stimulation in 14 patients (2009) (214)
Inhibition by sumatriptan of central trigeminal neurones only after blood‐brain barrier disruption (1993) (214)
Cost of Health Care Among Patients With Chronic and Episodic Migraine in Canada and the USA: Results From the International Burden of Migraine Study (IBMS) (2011) (212)
BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial (2014) (212)
Current practice and future directions in the prevention and acute management of migraine (2010) (210)
Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA)--a prospective clinical study of SUNCT and SUNA. (2006) (210)
Headache in Clinical Practice (1998) (202)
Neurobiology of migraine (2009) (201)
Towards a Definition of Intractable Headache for Use in Clinical Practice and Trials (2006) (196)
Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults (2018) (196)
P/Q-Type Calcium-Channel Blockade in the Periaqueductal Gray Facilitates Trigeminal Nociception: A Functional Genetic Link for Migraine? (2002) (193)
Galcanezumab in chronic migraine (2018) (191)
Galcanezumab in chronic migraine The randomized, double-blind, placebo-controlled REGAIN study (190)
Neuropeptides in Migraine and Cluster Headache (1994) (188)
Brainstem Influences on the Cephalic Circulation: Experimental Data From Cat and Monkey of Relevance to the Mechanism of Migraine (1983) (188)
Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine ? (1996) (188)
Glyceryl trinitrate triggers premonitory symptoms in migraineurs (2004) (184)
Effect of noninvasive vagus nerve stimulation on acute migraine: An open-label pilot study (2014) (182)
Activation of 5‐HT1B/1D receptor in the periaqueductal gray inhibits nociception (2004) (181)
Posterior hypothalamic activation in paroxysmal hemicrania (2006) (180)
Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine. (2019) (177)
Chronic migraine headache prevention with noninvasive vagus nerve stimulation (2016) (176)
Neural Processing of Craniovascular Pain: A Synthesis of the Central Structures Involved in Migraine (1991) (171)
Drug therapy: Migraine - Current understanding and treatment. (2002) (170)
Early vs. Non-Early Intervention in Acute Migraine — ‘Act When Mild (AwM)’. A Double-Blind, Placebo-Controlled Trial of Almotriptan (2008) (168)
Decreased carotid arterial resistance in cats in response to trigeminal stimulation. (1984) (167)
Stimulation of the superior sagittal sinus increases metabolic activity and blood flow in certain regions of the brainstem and upper cervical spinal cord of the cat. (1991) (165)
The Hypothalamic Orexinergic System: Pain and Primary Headaches (2007) (165)
Deep Brain Stimulation for Intractable Chronic Cluster Headache: Proposals for Patient Selection (2004) (165)
Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine. A c-Fos and electrophysiological study. (1996) (163)
Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial (2019) (163)
Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene‐related peptide induced dilation of dural meningeal vessels (2002) (162)
Stimulation of the greater occipital nerve increases metabolic activity in the trigeminal nucleus caudalis and cervical dorsal horn of the cat (1997) (161)
Neurovascular Headache and A Midbrain Vascular Malformation: Evidence for A Role of the Brainstem in Chronic Migraine (2002) (161)
Persistence of attacks of cluster headache after trigeminal nerve root section. (2002) (161)
'Visual snow' - a disorder distinct from persistent migraine aura. (2014) (160)
A meta-analysis for headache in systemic lupus erythematosus: the evidence and the myth. (2004) (159)
Peripheral and Central Trigeminovascular Activation in Cat is Blocked by the Serotonin (5HT)‐I D Receptor Agonist 311C90 (1994) (159)
Mechanisms and Mangement of Headache (1999) (156)
Obesity, migraine, and chronic migraine (2007) (154)
The vascular theory of migraine--a great story wrecked by the facts. (2009) (154)
Migraine Pathophysiology (2005) (153)
New therapeutic approaches for the prevention and treatment of migraine (2015) (153)
Nitric oxide synthesis couples cerebral blood flow and metabolism (1992) (151)
The Mode of Action of Sumatriptan is Vascular? A Debate (1994) (151)
Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine (2019) (148)
Gray matter changes related to chronic posttraumatic headache (2009) (145)
Hypnic headache (2003) (144)
Benign paroxysmal torticollis of infancy: four new cases and linkage to CACNA1A mutation. (2002) (143)
Pituitary volume and headache: size is not everything. (2004) (142)
Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A randomized, double-blind, sham-controlled ACT2 study (2017) (141)
Effectiveness of intranasal zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study. (2006) (141)
Migraine, aura, and cortical spreading depression: Why are we still talking about it? (2001) (141)
Localization of 3H‐Dihydroergotamine‐binding sites in the cat central nervous system: Relevance to migraine (1991) (140)
Trial of Galcanezumab in Prevention of Episodic Cluster Headache. (2019) (139)
Neuropeptide Changes in a case of Chronic Paroxysmal Hemicrania—Evidence for Trigemino-Parasympathetic Activation (1996) (139)
Treatment of hemicrania continua by occipital nerve stimulation with a bion device: long-term follow-up of a crossover study (2008) (139)
The pharmacology of headache (2000) (139)
Direct and Indirect Costs of Chronic and Episodic Migraine in the United States: A Web‐Based Survey (2016) (138)
Hemicrania continua: a clinical study of 39 patients with diagnostic implications. (2010) (138)
Anandamide Is Able to Inhibit Trigeminal Neurons Using an in Vivo Model of Trigeminovascular-Mediated Nociception (2004) (138)
Paroxysmal hemicrania: a prospective clinical study of 31 cases. (2008) (138)
Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: a role in migraine? (2004) (136)
Calcitonin gene-related peptide and pain: a systematic review (2017) (136)
Chronic migraine—classification, characteristics and treatment (2012) (134)
Intranasal sumatriptan in cluster headache (2003) (134)
Medication-overuse headache in patients with cluster headache (2006) (133)
Dopamine and Migraine: Biology and Clinical Implications (2007) (131)
The Relation Between Migraine, Typical Migraine Aura and “Visual Snow” (2014) (131)
Stimulation of the middle meningeal artery leads to Fos expression in the trigeminocervical nucleus: a comparative study of monkey and cat (1999) (130)
Microiontophoretic application of serotonin (5HT)1B/1D agonists inhibits trigeminal cell firing in the cat. (1997) (130)
Diagnostic delays and mis‐management in cluster headache (2004) (129)
Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors (2004) (128)
Eletriptan in acute migraine (2000) (128)
Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition (2019) (127)
Topiramate inhibits cortical spreading depression in rat and cat: impact in migraine aura (2005) (127)
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention? (2017) (123)
PACAP, a VIP-like Peptide: Immunohistochemical Localization and Effect upon Cat Pial Arteries and Cerebral Blood Flow (1993) (123)
Sumatriptan can inhibit trigeminal afferents by an exclusively neural mechanism. (1996) (123)
Utility of Topiramate for the Treatment of Patients with Chronic Migraine in the Presence or Absence of Acute Medication Overuse (2009) (123)
Oxygen Inhibits Neuronal Activation in the Trigeminocervical Complex After Stimulation of Trigeminal Autonomic Reflex, But Not During Direct Dural Activation of Trigeminal Afferents (2009) (122)
Defining Refractory Migraine and Refractory Chronic Migraine: Proposed Criteria From the Refractory Headache Special Interest Section of the American Headache Society (2008) (122)
Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A Randomized Clinical Trial (2017) (122)
A randomized controlled trial of intranasal ketamine in migraine with prolonged aura (2013) (121)
Diagnostic Criteria for Headache Due to Spontaneous Intracranial Hypotension: A Perspective (2011) (120)
Neuropeptides in the Cerebral Circulation: Relevance to Headache (1995) (119)
Orexin 1 Receptor Activation Attenuates Neurogenic Dural Vasodilation in an Animal Model of Trigeminovascular Nociception (2005) (119)
Familial typical migraine (1998) (119)
Trigeminovascular nociceptive transmission involves N-methyl-d-aspartate and non-N-methyl-d-aspartate glutamate receptors (1999) (118)
Subcutaneous octreotide in cluster headache: Randomized placebo‐controlled double‐blind crossover study (2004) (118)
Initial use of a novel noninvasive vagus nerve stimulator for cluster headache treatment (2015) (118)
Differential effects on the internal and external carotid circulation of the monkey evoked by locus coeruleus stimulation (1982) (116)
Animal models of migraine: looking at the component parts of a complex disorder (2006) (116)
Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5‐hydroxy‐tryptamine (5‐HT1B/1D) receptors (1997) (113)
Single-pulse transcranial magnetic stimulation (sTMS) for the acute treatment of migraine: evaluation of outcome data for the UK post market pilot program (2015) (112)
Unilateral Photophobia or Phonophobia in Migraine Compared With Trigeminal Autonomic Cephalalgias (2008) (112)
Modulation of nociceptive dural input to the trigeminal nucleus caudalis via activation of the orexin 1 receptor in the rat (2006) (112)
Pituitary adenylate cyclase activating polypeptide and migraine (2014) (111)
Effect of stimulation of trigeminal ganglion on regional cerebral blood flow in cats. (1987) (110)
No change in the structure of the brain in migraine: a voxel‐based morphometric study (2003) (108)
An update on migraine: current understanding and future directions (2017) (108)
Electrocardiographic abnormalities in patients with cluster headache on verapamil therapy (2007) (108)
Calcitonin gene-related peptide and nitric oxide in the trigeminal ganglion: cerebral vasodilatation from trigeminal nerve stimulation involves mainly calcitonin gene-related peptide. (1998) (107)
Magnetic Resonance Angiography in Facial and other Pain: Neurovascular Mechanisms of Trigeminal Sensation (2001) (107)
Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in migraine (2016) (106)
Neurons of the Dopaminergic/Calcitonin Gene-Related Peptide A11 Cell Group Modulate Neuronal Firing in the Trigeminocervical Complex: An Electrophysiological and Immunohistochemical Study (2009) (105)
Hypothalamic activation after stimulation of the superior sagittal sinus in the cat: a Fos study (2004) (104)
Evidence for an X-linked genetic component in familial typical migraine. (1998) (104)
Oral zolmitriptan is effective in the acute treatment of cluster headache (2000) (103)
Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing syndrome: a review (2003) (103)
Neuronal PAC1 receptors mediate delayed activation and sensitization of trigeminocervical neurons: Relevance to migraine (2015) (102)
Current concepts of the pathophysiology of migraine. (1997) (102)
Intravenous dihydroergotamine for inpatient management of refractory primary headaches (2011) (102)
Prolactinomas, dopamine agonists and headache: two case reports (2003) (100)
Cannabinoid (CB1) Receptor Activation Inhibits Trigeminovascular Neurons (2007) (98)
Fos expression in the trigeminocervical complex of the cat after stimulation of the superior sagittal sinus is reduced by l-NAME (1999) (97)
Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial (2020) (97)
Behavioral management of the triggers of recurrent headache: a randomized controlled trial. (2014) (97)
Why headache treatment fails (2003) (97)
A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study) (2018) (96)
Dopamine: what's new in migraine? (2010) (95)
Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study of the Cortical Spreading Depression Inhibiting Agent Tonabersat in Migraine Prophylaxis (2009) (95)
Extracranial vasodilatation mediated by vasoactive intestinal polypeptide (VIP) (1985) (95)
Assessing the risk of central post-stroke pain of thalamic origin by lesion mapping. (2012) (95)
Efficacy and Safety of Eptinezumab in Patients With Chronic Migraine: PROMISE-2. (2023) (95)
SUNCT Syndrome Responsive to Intravenous Lidocaine (2004) (95)
Dopamine inhibits trigeminovascular transmission in the rat (2007) (94)
Obesity, migraine, and chronic migraine Possible mechanisms of interaction (94)
Migraine pathogenesis and state of pharmacological treatment options (2009) (94)
Substance P receptor antagonists in the therapy of migraine (2001) (93)
Acid‐sensing ion channel 1: A novel therapeutic target for migraine with aura (2012) (93)
Endocannabinoids in the Brainstem Modulate Dural Trigeminovascular Nociceptive Traffic via CB1 and “Triptan” Receptors: Implications in Migraine (2013) (92)
European headache federation consensus on technical investigation for primary headache disorders (2015) (92)
Modulation of nocioceptive transmission with calcitonin gene-related peptide receptor antagonists in the thalamus. (2010) (92)
Ophthalmoplegic “Migraine” or Recurrent Ophthalmoplegic Cranial Neuropathy (2012) (92)
Vanilloid type 1 receptors (VR1) on trigeminal sensory nerve fibres play a minor role in neurogenic dural vasodilatation, and are involved in capsaicin‐induced dural dilation (2003) (91)
The migraine postdrome (2016) (90)
EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force (2009) (90)
Serotonin receptors modulate trigeminovascular responses in ventroposteromedial nucleus of thalamus: A migraine target? (2006) (90)
Voltage‐dependent calcium channels are involved in neurogenic dural vasodilatation via a presynaptic transmitter release mechanism (2003) (90)
Clinical features of migraine aura: Results from a prospective diary-aided study (2017) (89)
Topiramate Inhibits Trigeminovascular Neurons in the Cat (2004) (89)
Oral sumatriptan in acute migraine (1991) (89)
Adenosine A1 receptor agonists inhibit trigeminovascular nociceptive transmission. (2002) (89)
Fos expression in the midbrain periaqueductal grey after trigeminovascular stimulation (2001) (89)
Biological insights from the premonitory symptoms of migraine (2018) (88)
Efficacy and safety of eptinezumab in patients with chronic migraine (2020) (88)
Cerebral vasodilatation in the cat involves nitric oxide from parasympathetic nerves (1996) (88)
An Update: Pathophysiology of Migraine. (2019) (87)
Neuropeptides in headache (1998) (87)
Activation of the Trigeminovascular System by Mechanical Distension of the Superior Sagittal Sinus in The Cat (1992) (87)
Intravenous Acetylsalicylic Acid Inhibits Central Trigeminal Neurons in the Dorsal Horn of the Upper Cervical Spinal Cord in the Cat (1993) (86)
Diffusion- and Perfusion-Weighted MR Imaging in Persistent Migrainous visual Disturbances (2005) (86)
Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial (2021) (85)
SUNCT syndrome: prolonged attacks, refractoriness and response to topiramate. (2002) (85)
Migraine: Preventive Treatment (2002) (84)
Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trial (2019) (84)
Anti-migraine compounds fail to modulate the propagation of cortical spreading depression in the cat. (1994) (84)
Sphenopalatine ganglion stimulation increases regional cerebral blood flow independent of glucose utilization in the cat (1990) (84)
SUNCT Syndrome or Trigeminal Neuralgia with Lacrimation (2001) (83)
TEV-48125 for the preventive treatment of chronic migraine (2016) (83)
Migraine: Diagnosis and assessment of disability (2000) (83)
Retinal plasma extravasation in animals but not in humans: implications for the pathophysiology of migraine. (1998) (82)
Neurostimulation approaches to primary headache disorders (2009) (82)
Evidence for serotonin (5-HT)1B, 5-HT1D and 5-HT1F receptor inhibitory effects on trigeminal neurons with craniovascular input (2003) (82)
SUNCT syndrome secondary to prolactinoma (2003) (81)
Comparative efficacy of triptans for the abortive treatment of migraine: A multiple treatment comparison meta-analysis (2014) (81)
New onset migraine with a brain stem cavernous angioma (2003) (81)
Serotonin 5-HT1B/1D Receptor Agonists in Migraine (1998) (80)
Post-traumatic chronic paroxysmal hemicrania (CPH) with aura (2001) (80)
Cluster headache, hypothalamus, and orexin (2009) (80)
Trigeminal Autonomic Cephalalgias: Current and Future Treatments (2007) (79)
Glutamatergic transmission in the trigeminal nucleus assessed with local blood flow (2000) (79)
Chronic daily headache: nosology and pathophysiology (2002) (78)
Sumatriptan Reverses the Changes in Calcitonin Gene-Related Peptide Seen in the Headache Phase of Migraine (1991) (77)
Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine (2019) (77)
Trigeminal autonomic cephalalgias: diagnostic and therapeutic developments (2008) (76)
Occipital afferent activation of second order neurons in the trigeminocervical complex in rat (2006) (76)
Low frequency stimulation of the locus coeruleus reduces regional cerebral blood flow in the spinalized cat (1989) (76)
Placebo Response in Cluster Headache Trials: A Review (2003) (76)
A translational in vivo model of trigeminal autonomic cephalalgias – therapeutic characterization with brainstem stimulation (2012) (75)
Migraine, Allodynia, Sensitisation and All of That ... (2005) (75)
Direct Evidence for Central Sites of Action of Zolmitriptan (311C90) (1997) (75)
Topiramate inhibits trigeminovascular activation: an intravital microscopy study (2005) (75)
Alopecia and cutaneous atrophy after greater occipital nerve infiltration with corticosteroid (2004) (74)
Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial (2020) (74)
Anatomy and Physiology of Pain Referral Patterns in Primary and Cervicogenic Headache Disorders (2005) (74)
Occipital Nerve Stimulation for Headache: Mechanisms and Efficacy (2008) (74)
Imaging patients with suspected brain tumour: guidance for primary care. (2008) (73)
Stimulation of the Trigeminal ganglion increases flow in the extracerebral but not the cerebral circulation of the monkey (1986) (73)
The effect of anti-migraine compounds on nitric oxide-induced dilation of dural meningeal vessels. (2002) (73)
Comparative effects of stimulation of the trigeminal ganglion and the superior sagittal sinus on cerebral blood flow and evoked potentials in the cat (1988) (73)
Trigeminal autonomic cephalalgias: paroxysmal hemicrania, SUNCT/SUNA, and hemicrania continua. (2010) (72)
Changes in Neurocognitive Architecture in Patients with Obstructive Sleep Apnea Treated with Continuous Positive Airway Pressure (2016) (72)
Clinical features of headache at altitude (2003) (72)
Occipital nerve stimulation in medically intractable, chronic cluster headache. The ICON study: Rationale and protocol of a randomised trial (2013) (71)
Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment (2020) (71)
Photic hypersensitivity in the premonitory phase of migraine – a positron emission tomography study (2014) (70)
Cranial autonomic symptoms in pediatric migraine are the rule, not the exception (2013) (70)
Migraine among medical students in Kuwait University (2014) (70)
Topiramate in the treatment of migraine: A kainate (glutamate) receptor antagonist within the trigeminothalamic pathway (2011) (69)
Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults (2020) (69)
Effect of the Adenosine A1 Receptor Agonist Gr79236 on Trigeminal Nociception with Blink Reflex Recordings in Healthy Human Subjects (2003) (69)
Autonomic nervous system control of the cerebral circulation. (2013) (68)
The Premonitory Phase of Migraine – What Can We Learn From It? (2015) (67)
The origin of nausea in migraine–A PET study (2014) (67)
Can we Develop Neurally Acting Drugs for the Treatment of Migraine? (2005) (67)
A triptan too far? (1998) (66)
Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy (2018) (66)
Recent advances in the diagnosis and management of migraine (2006) (66)
Patterns of fos expression in the rostral medulla and caudal pons evoked by noxious craniovascular stimulation and periaqueductal gray stimulation in the cat (2005) (65)
Update on the prophylaxis of migraine (2008) (64)
Animal models of headache: from bedside to bench and back to bedside (2010) (64)
Functional neuroimaging of primary headache disorders (2004) (64)
Migraine: disease characterisation, biomarkers, and precision medicine (2021) (64)
Inhibition of nociceptive dural input in the trigeminal nucleus caudalis by somatostatin receptor blockade in the posterior hypothalamus (2005) (64)
Calcitonin gene-related peptide and migraine. (2015) (64)
Double-Blind Clinical Trials of Oral Triptans Vs Other Classes of Acute Migraine Medication — A Review (2004) (64)
Migraine in the Triptan Era: Lessons From Epidemiology, Pathophysiology, and Clinical Science (2009) (63)
Cluster headache and related conditions (1999) (63)
Mechanisms of action of serotonin 5-HT1B/D agonists: insights into migraine pathophysiology using rizatriptan. (2000) (62)
The NMDA receptor antagonist MK-801 reduces Fos-like immunoreactivity within the trigeminocervical complex following superior sagittal sinus stimulation in the cat (2001) (62)
Efficacy and safety of erenumab (AMG334) in episodic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study (2018) (62)
Evidence for orexinergic mechanisms in migraine (2015) (62)
Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5ht 1b/1D receptor: A central action in migraine? (1998) (62)
How do the Currently Used Prophylactic Agents Work in Migraine? (1997) (62)
Effects of locus coeruleus stimulation on carotid vascular resistance in the cat (1983) (62)
Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288 (1999) (61)
The peripheral pathway for extracranial vasodilatation in the cat. (1984) (61)
A Neurologist’s Guide to Acute Migraine Therapy in the Emergency Room (2012) (61)
Differential effects of low dose CP122,288 and eletriptan on Fos expression due to stimulation of the superior sagittal sinus in cat☆ (1999) (61)
GABA and valproate modulate trigeminovascular nociceptive transmission in the thalamus (2010) (60)
New Agents for Acute Treatment of Migraine: CGRP Receptor Antagonists, iNOS Inhibitors (2012) (59)
Management of Trigeminal Autonomic Cephalgias and Hemicrania Continua (2012) (59)
Pathophysiology of migraine. (2009) (59)
Secondary cluster headache responsive to sumatriptan. (1995) (59)
Phenotype of patients responsive to occipital nerve stimulation for refractory head pain (2010) (59)
The typical duration of migraine aura: A systematic review (2013) (58)
Acute Migraine Therapy: New Drugs and New Approaches (2010) (58)
A potential nitrergic mechanism of action for indomethacin, but not of other COX inhibitors: relevance to indomethacin-sensitive headaches (2010) (58)
Characteristics of facial nerve-elicited cerebral vasodilatation determined using laser Doppler flowmetry. (1991) (58)
Variability of clinical features in attacks of migraine with aura (2016) (57)
The International Burden of Migraine Study (IBMS): Study design, methodology, and baseline cohort characteristics (2011) (57)
Fortnightly Review: Diagnosis and management of migraine (1996) (57)
Emerging therapies for migraine (2007) (57)
Ictal lack of binding to brain parenchyma suggests integrity of the blood–brain barrier for 11 C-dihydroergotamine during glyceryl trinitrate-induced migraine (2016) (57)
The Role of Melatonin in the Treatment of Primary Headache Disorders (2016) (57)
Atogepant for the Preventive Treatment of Migraine. (2021) (57)
Zolmitriptan, a 5‐HT1B/1D receptor agonist for the acute oral treatment of migraine: a multicentre, dose‐range finding study (1998) (56)
Stimulation of an intracranial trigeminally-innervated structure selectively increases cerebral blood flow 1 These data were presented in part at the XVIIth International Symposium on Cerebral Blood Flow and Metabolism, Cologne, July, 1995 [27]. 1 (1997) (56)
Morphological Abnormalities of Thalamic Subnuclei in Migraine: A Multicenter MRI Study at 3 Tesla (2015) (55)
Hypothalamic involvement and activation in cluster headache (2001) (55)
Update on intracranial hypertension and hypotension. (2013) (55)
The anterior insula shows heightened interictal intrinsic connectivity in migraine without aura (2015) (55)
Introduction: On the Functional Neuroanatomy of Neck Pain (2008) (55)
Distribution of 5-HT1B, 5-HT1D and 5-HT1F receptor expression in rat trigeminal and dorsal root ganglia neurons: Relevance to the selective anti-migraine effect of triptans (2010) (54)
Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial (2019) (53)
Identifying Natural Subgroups of Migraine Based on Comorbidity and Concomitant Condition Profiles: Results of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study (2018) (52)
Visual snow syndrome: what we know so far (2017) (52)
Amylin: Localization, Effects on Cerebral Arteries and on Local Cerebral Blood Flow in the Cat (2001) (52)
Significance of atypical presentation of symptomatic SUNCT: a case report (2001) (51)
Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs (2018) (51)
Comparison of More and Less Lipophilic Serotonin (5HT1B/1D) Agonists in a Model of Trigeminovascular Nociception in Cat (1998) (50)
Trigeminal antinociception induced by bicuculline in the periaqueductal gray (PAG) is not affected by PAG P/Q-type calcium channel blockade in rat (2003) (50)
Therapeutic potential of novel glutamate receptor antagonists in migraine. (2009) (50)
Inhibition of calcitonin gene-related peptide by h-CGRP(8–37) antagonizes the cerebral dilator response from nasociliary nerve stimulation in the cat (1993) (50)
A PET study in spontaneous migraine (2004) (50)
Persistent and Repetitive Visual Disturbances in Migraine: A Review (2017) (50)
Evidence for postjunctional serotonin (5‐HT1) receptors in the trigeminocervical complex (2001) (50)
Glutamatergic fine tuning with ADX-10059: a novel therapeutic approach for migraine? (2010) (50)
Cluster Headache: Epidemiology, Pathophysiology, Clinical Features, and Diagnosis (2018) (50)
Cluster headache (2012) (50)
Identification of Negative Predictors of Pain-Free Response to Triptans: Analysis of the Eletriptan Database (2008) (49)
An Update on Non‐Pharmacological Neuromodulation for the Acute and Preventive Treatment of Migraine (2017) (49)
Triptan nonresponders: Do they exist and who are they? (2013) (49)
Cluster Headache (2000) (49)
Naratriptan is effective and well tolerated in the acute treatment of migraine. (1999) (48)
Migraine association and linkage studies of an endothelial nitric oxide synthase (NOS3) gene polymorphism (1997) (48)
Calcitonin Gene-Related Peptide Antagonists as Treatments of Migraine and Other Primary Headaches (2012) (48)
What has functional neuroimaging done for primary headache … and for the clinical neurologist? (2010) (48)
Safety and efficacy of flunarizine in childhood migraine: 11 years’ experience, with emphasis on its effect in hemiplegic migraine (2012) (47)
Structural and functional footprint of visual snow syndrome (2020) (47)
CGRP Mechanism Antagonists and Migraine Management (2015) (47)
Intravital Microscopy on a Closed Cranial Window in Mice: A Model to Study Trigeminovascular Mechanisms Involved in Migraine (2006) (47)
Intracranial Vessels in Trigeminal Transmitted Pain: A PET Study (1999) (46)
Before the headache (2012) (46)
Medication-overuse headache in patients with cluster headache (2008) (46)
Effect of stimulation of nucleus raphe dorsalis on carotid blood flow. I. The monkey. (1985) (46)
Effect of stimulation of facial nerve on regional cerebral blood flow and glucose utilization in cats. (1989) (45)
Hypothalamic grey activation is specific for attacks of cluster headache. (1999) (45)
Neurostimulation in primary headache syndromes (2007) (45)
Trigeminal autonomic cephalalgias: Diagnosis and treatment (2007) (45)
TRPV1 receptor blockade is ineffective in different in vivo models of migraine (2011) (44)
Hypnic Headache (2005) (44)
Calcitonin gene-related peptide receptor antagonist BIBN4096BSfor the acute treatment of migraine (2004) (44)
Mechanically-induced cortical spreading depression associated regional cerebral blood flow changes are blocked by Na+ ion channel blockade (2008) (44)
Cortical abnormalities in episodic migraine: A multi-center 3T MRI study (2018) (44)
Characterising the premonitory stage of migraine in children: a clinic-based study of 100 patients in a specialist headache service (2016) (44)
Outcomes of greater occipital nerve injections in pediatric patients with chronic primary headache disorders. (2014) (44)
Substance P blockade with the potent and centrally acting antagonist GR205171 does not effect central trigeminal activity with superior sagittal sinus stimulation 1 These data were presented in preliminary form to the 8th International Headache Congress, Amsterdam, June 1997.[26] 1 (1998) (44)
Migraine aura symptoms: Duration, succession and temporal relationship to headache (2016) (44)
Measurement of vasoactive neuropeptides in biological materials: Problems and pitfalls from 30 years of experience and novel future approaches (2010) (43)
Gepants, calcitonin-gene-related peptide receptor antagonists: what could be their role in migraine treatment? (2020) (43)
Central mechanisms of peripheral nerve stimulation in headache disorders. (2011) (43)
Positive persistent visual symptoms (visual snow) presenting as a migraine variant in a 12-year-old girl. (2013) (43)
Variability of the characteristics of a migraine attack within patients (2016) (43)
Vasoactive intestinal peptide (VIP) like peptides in the cerebral circulation of the cat. (1994) (43)
The ‘Act When Mild’ (AwM) Study: A Step Forward in Our Understanding of Early Treatment in Acute Migraine (2008) (43)
Secondary “hypnic headache- (2007) (43)
Practical management of medication-overuse headache. (2006) (43)
Phenotypic and treatment outcome data on SUNCT and SUNA, including a randomised placebo-controlled trial (2017) (43)
Safety and efficacy of sphenopalatine ganglion stimulation for chronic cluster headache: a double-blind, randomised controlled trial (2019) (43)
”Paratrigeminal” paralysis of the oculopupillary sympathetic system (2002) (42)
Zolmitriptan Intranasal: A Review of the Pharmacokinetics and Clinical Efficacy (2006) (42)
A simple method, using 2-hydroxypropyl-β-cyclodextrin, of administering α-chloralose at room temperature (1997) (42)
What Happens to New-Onset Headache Presented to Primary Care? A Case-Cohort Study Using Electronic Primary Care Records (2008) (42)
Calcitonin gene-related peptide: A molecular link between obesity and migraine? (2010) (41)
The trigeminovascular system does not require a peripheral sensory input to be activated – migraine is a central disorder Focus on ‘Effect of cortical spreading depression on basal and evoked traffic in the trigeminovascular sensory system’ (2012) (41)
Recommendations on the Use of Anti‐CGRP Monoclonal Antibodies in Children and Adolescents (2018) (41)
NEW DAILY PERSISTENT HEADACHE (2002) (41)
Epidemiology, Risk Factors, and Treatment of Chronic Migraine: A Focus on Topiramate (2008) (41)
Deficits in the function of small and large afferent fibers in confirmed cases of carpal tunnel syndrome (1994) (41)
MRI in headache (2013) (41)
Joint 1994 Wolff Award Presentation. Peripheral and central trigeminovascular activation in cat is blocked by the serotonin (5HT)-1D receptor agonist 311C90. (1994) (41)
Imaging the Visual Network in the Migraine Spectrum (2019) (41)
Benign Cough Headache (2002) (41)
The mechanism of cerebrovascular vasoconstriction in response to locus coeruleus stimulation (1985) (41)
Migraine in pregnancy (2008) (41)
Migraine headache is present in the aura phase (2012) (40)
Migraine headache is present in the aura phase – a prospective study (2013) (40)
Emerging Targets in Migraine (2013) (40)
Comparative tolerability of treatments for acute migraine: A network meta-analysis (2017) (40)
Proposals for New Standardized General Diagnostic Criteria for the Secondary Headaches (2009) (40)
Bench to bedside advances in the 21st century for primary headache disorders: migraine treatments for migraine patients. (2016) (40)
Serotonin receptors and the acute attack of migraine. (1998) (40)
Cortical spreading depression-associated cerebral blood flow changes induced by mechanical stimulation are modulated by AMPA and GABA receptors (2010) (40)
Visual snow syndrome (2020) (40)
Defining Refractory Migraine: Results of the RHSIS Survey of American Headache Society Members (2009) (39)
Management of migraine: an algorithmic approach. (2000) (39)
The Scientific Basis of Medication Choice in Symptomatic Migraine Treatment (1999) (39)
Is migraine a risk factor for pediatric stroke? (2015) (39)
Clinicopathological correlation in a case of painful ophthalmoplegia: Tolosa-Hunt syndrome. (1989) (39)
Activation of iGluR5 kainate receptors inhibits neurogenic dural vasodilatation in an animal model of trigeminovascular activation (2009) (38)
Trigeminocervical complex responses after lesioning dopaminergic A11 nucleus are modified by dopamine and serotonin mechanisms (2011) (38)
Migraine Association and Linkage Analyses of the Human 5-Hydroxytryptamine (5HT2A) Receptor Gene (1996) (38)
Properties of neurons in the trigeminal nucleus caudalis responding to noxious dural and facial stimulation (2005) (38)
One-year sustained efficacy of erenumab in episodic migraine (2020) (38)
Transcranial magnetic stimulation for the treatment of migraine aura (2009) (38)
The migraine postdrome. (2016) (38)
Periaqueductal gray calcitonin gene-related peptide modulates trigeminovascular neurons (2015) (38)
The Migraine Premonitory Phase (2018) (37)
Subcortical Cerebral Blood Flow and Metabolic Changes Elicited by Cortical Spreading Depression in Rat (1992) (37)
Effect of Rizatriptan and Other Triptans on the Nausea Symptom of Migraine: A Post Hoc Analysis (2001) (37)
Insular and occipital changes in visual snow syndrome: a BOLD fMRI and MRS study (2020) (37)
To scan or not to scan in headache (2004) (37)
Verapamil induced gingival enlargement in cluster headache (2004) (37)
Neuroendocrine signaling modulates specific neural networks relevant to migraine (2017) (37)
Functional MRI in SUNCT shows differential hypothalamic activation with increasing pain (2004) (37)
Comparison of the Effects of Central and Peripheral Dopamine Receptor Activation on Evoked Firing in the Trigeminocervical Complex (2009) (36)
Use of sumatriptan in post-ictal migraine headache (1996) (36)
Neuropeptide Y inhibits the trigeminovascular pathway through NPY Y1 receptor: implications for migraine (2016) (36)
Medication Overuse in Children and Adolescents (2014) (36)
Occipital activation in glyceryl trinitrate induced migraine with visual aura (2005) (36)
Trigeminal autonomic cephalalgias. (2016) (36)
The effect of adrenergic compounds on neurogenic dural vasodilatation. (2001) (35)
Treatment of disabling headache with greater occipital nerve injections in a large population of childhood and adolescent patients: a service evaluation (2018) (35)
5-Hydroxytryptamine and its putative aetiological involvement in migraine (1989) (35)
GABA receptors modulate trigeminovascular nociceptive neurotransmission in the trigeminocervical complex (2001) (35)
The Long Drought: The Dearth of Public Funding for Headache Research (2007) (35)
Efficacy and mechanism of anticonvulsant drugs in migraine (2014) (34)
Visual Snow—Persistent Positive Visual Phenomenon Distinct from Migraine Aura (2015) (34)
Mechanisms of cluster headache. (1999) (34)
Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label study (2020) (34)
Experts’ opinion about the primary headache diagnostic criteria of the ICHD-3rd edition beta in children and adolescents (2017) (34)
Non-invasive vagus nerve stimulation for the treatment of cluster headache: a case series (2013) (33)
Triptans in Orgasmic Headache (2006) (33)
Migraine misdiagnosis as a sinusitis, a delay that can last for many years (2013) (33)
Is medication-overuse headache a distinct biological entity? (2006) (33)
Zolmitriptan Nasal Spray in the Acute Treatment of Cluster Headache: A Meta‐Analysis of Two Studies (2009) (33)
Calcium channels modulate nociceptive transmission in the trigeminal nucleus of the cat (2005) (33)
New targets in the acute treatment of headache (2005) (33)
Chronic headache and pituitary tumors (2008) (33)
Recent advances in headache neuroimaging (2018) (33)
High-frequency stimulation of the facial nerve results in local cortical release of vasoactive intestinal polypeptide in the anesthetised cat (1990) (33)
Headache-related health resource utilisation in chronic and episodic migraine across six countries (2013) (33)
How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians (2005) (33)
Treatment-Emergent CNS Symptoms Following Triptan Therapy are Part of The Attack (2007) (33)
SUNCT Syndrome in the Elderly (2004) (32)
Trigeminal autonomic cephalalgias. Pathophysiology and classification. (2005) (32)
Trigeminal-Autonomic Cephalgias (TACs) (1998) (32)
Inhibition of trigeminovascular dural nociceptive afferents by Ca2+-activated K+ (MaxiK/BKCa) channel opening (2010) (32)
Synthesis of migraine mechanisms (2006) (32)
Plasma neuropeptide Y in the symptomatic limb of patients with causalgic pain (1994) (32)
The role of histamine in dural vessel dilation (2002) (32)
Classification and epidemiology of headache. (1999) (31)
Aura and Head pain: relationship and gaps in the translational models (2019) (31)
PET demonstration of hypothalamic activation in cluster headache (1999) (31)
Flunarizine in migraine‐related headache prevention: results from 200 patients treated in the UK (2018) (31)
Differential efficacy of non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A meta-analysis (2019) (31)
The relationship between migraine and infant colic: A systematic review and meta-analysis (2015) (31)
The Hospital Management of Severe Migrainous Headache (1991) (31)
CHRONIC DAILY HEADACHE (2002) (31)
Differential medication overuse risk of novel anti-migraine therapeutics. (2020) (30)
Short-lasting primary headaches: focus on trigeminal automatic cephalgias and indomethacin-sensitive headaches. (1999) (30)
Divergent influences of the locus coeruleus on migraine pathophysiology (2018) (30)
4991W93 inhibits release of calcitonin gene-related peptide in the cat but only at doses with 5HT1B/1D receptor agonist activity? (2001) (30)
Visual snow syndrome A clinical and phenotypical description of 1,100 cases (30)
Refractory Migraine and Chronic Migraine: Pathophysiological Mechanisms (2008) (30)
Immunohistochemical characterization of calcitonin gene-related peptide in the trigeminal system of the familial hemiplegic migraine 1 knock-in mouse (2011) (30)
The use of multiattribute decision models in evaluating triptan treatment options in migraine (2005) (30)
Statistical methods in clinical trials (2003) (30)
Trigeminal autonomic cephalalgias: diagnosis and management (2008) (30)
Migraine progression in subgroups of migraine based on comorbidities (2019) (30)
New Daily Persistent Headache: A Syndrome Not a Discrete Disorder (2011) (30)
Treatment of pediatric migraine in the emergency room. (2012) (29)
Paroxysmal hemicrania responding to topiramate (2006) (29)
Serotonin receptor ligands: treatments of acute migraine and cluster headache. (2007) (29)
Metabotropic glutamate receptor 5: a target for migraine therapy (2016) (29)
Targeting CGRP and 5‐HT1F Receptors for the Acute Therapy of Migraine: A Literature Review (2019) (29)
Nitroglycerine triggers triptan-responsive cranial allodynia and trigeminal neuronal hypersensitivity. (2019) (29)
Premature stop codons in a facilitating EF-hand splice variant of CaV2.1 cause episodic ataxia type 2 (2008) (29)
Extracerebral manifestations in migraine. A peptidergic involvement? (1990) (29)
Cluster headache: imaging and other developments. (1998) (28)
Safety and tolerability of ubrogepant following intermittent, high-frequency dosing: Randomized, placebo-controlled trial in healthy adults (2019) (28)
Motion sickness, migraine, and menstruation in mariners (1998) (28)
Noninvasive Vagus Nerve Stimulation for Treatment of Indomethacin-Sensitive Headaches (2017) (28)
Gray matter volume modifications in migraine (2018) (28)
Predictors of Migraine Headache Recurrence: A Pooled Analysis From the Eletriptan Database (2007) (28)
Neuropsychiatric Side-Effects of Lidocaine: Examples from the Treatment of Headache and a Review (2009) (28)
Octreotide is not Effective in the Acute Treatment of Migraine (2005) (28)
Functional brain imaging in hemicrania continua: Implications for nosology and pathophysiology (2005) (27)
Transcranial Magnetic Stimulation for Migraine Prevention in Adolescents: A Pilot Open‐Label Study (2018) (27)
Coincidence of Familial Hemiplegic Migraine and Hemicrania Continua? A Case Report (1999) (27)
Reduced efficacy of sumatriptan in migraine with aura vs without aura (2015) (27)
Almotriptan and zolmitriptan in the acute treatment of migraine. (2007) (27)
Cluster and related headaches. (2001) (27)
Update on Hemicrania Continua (2010) (27)
PAC1 receptor blockade reduces central nociceptive activity: new approach for primary headache? (2020) (26)
Trigeminal neuropathic pain in a patient with progressive facial hemiatrophy (parry-romberg syndrome). (2011) (26)
Time-To-Event Analysis, Or Who Gets Better Sooner? an Emerging Concept in Headache Study Methodology (1999) (26)
Suggested guidelines for treating SUNCT and SUNA (2005) (26)
Cutaneous Sensory Stimulation Leading to Facial Flushing and Release of Calcitonin Gene-Related Peptide (1992) (26)
CGRP – a target for acute therapy in migraine: Clinical data (2019) (26)
Trigeminal autonomic cephalalgias: fancy term or constructive change to the IHS classification? (2005) (26)
International Classification of Headache Disorders - ICHD-4 alpha (2020) (26)
Therapeutic potential of novel glutamate receptor antagonists in migraine (2009) (25)
Contribution of experimental studies to understanding the pathophysiology of migraine (1990) (25)
Therapeutic prospects for migraine: Can paradise be regained? (2013) (25)
The Association between Calcitonin Gene-Related Peptide (CGRP), Substance P and Headache in Pituitary Tumours (2005) (25)
Disorders of the auditory system (2002) (25)
GABAA receptor modulation of trigeminovascular nociceptive neurotransmission by midazolam is antagonized by flumazenil (2004) (25)
Acromegaly: A Unique Human Headache Model (2003) (25)
The clinical profile of sumatriptan: cluster headache. (1994) (25)
Migraine: emerging treatment options for preventive and acute attack therapy (2006) (24)
Orally Administered Atogepant Was Efficacious, Safe, and Tolerable for the Prevention of Migraine: Results From a Phase 2b/3 Study (S17.001) (2019) (24)
32 – Migraine as a Cerebral Ionopathy with Abnormal Central Sensory Processing* (2007) (24)
MANGANESE deficiency. (2022) (24)
Calcitonin gene-related peptide-targeting drugs for migraine: how pharmacology might inform treatment decisions (2022) (24)
TRIPSTAR: prioritizing oral triptan treatment attributes in migraine management (2004) (24)
Pathophysiology of migraine: a disease of the brain (1997) (24)
Neuroimaging in headache (2001) (24)
Characterization of opioid receptors that modulate nociceptive neurotransmission in the trigeminocervical complex (2003) (24)
Cluster headache: A review of neuroimaging findings (2007) (24)
Chronic tension-type headache. (2002) (24)
Cortical spreading depression--better understanding and more questions. Focus on "distinct vascular conduction with cortical spreading depression". (2007) (24)
Chronic tension-type headache: where are we? (1999) (24)
The Impact of Allodynia on the Efficacy of Almotriptan When Given Early in Migraine: Data From the “Act When Mild” Study (2011) (24)
Functional neuroimaging of primary headache disorders (2006) (23)
Lacrimation, conjunctival injection, nasal symptoms… cluster headache, migraine and cranial autonomic symptoms in primary headache disorders—what’s new? (2009) (23)
5-Hydroxytryptamine and its Putative Aetiological Involvement in Migraine (1989) (23)
Managing cluster headache (2019) (23)
Headache-related disability in the management of migraine (2001) (23)
Advances in the understanding of headache. (2005) (23)
Recent Advances in Pharmacotherapy for Episodic Migraine (2019) (23)
Wilfred Harris' Early Description of Cluster Headache (2002) (22)
LY466195, a clinically active compound in the acute treatment of migraine, inhibits activation in the trigeminocervical complex and the ventroposteromedial thalamus after nociceptive trigeminovascular activation (2009) (22)
Current Approaches to Neuromodulation in Primary Headaches: Focus on Vagal Nerve and Sphenopalatine Ganglion Stimulation (2016) (22)
Benign paroxysmal torticollis of infancy: four new cases and linkage to CACNA1A mutation (2002) (22)
Paroxysmal Hemicrania‐Tic Syndrome (2001) (22)
Effect of stimulation of nucleus raphe dorsalis on carotid blood flow. II. The cat. (1985) (22)
Characterization of Endothelin Receptors in the Cerebral Vasculature and Their Lack of Effect on Spreading Depression (1996) (22)
Calcitonin gene-related peptide (CGRP) antagonists and migraine (2008) (22)
The Paroxysmal Hemicrania-Tic Syndrome (2003) (22)
Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project). (2004) (22)
Migraine and multiple sclerosis: Epidemiology and approach to treatment. (2013) (22)
Efficacy of galcanezumab in patients with episodic migraine and a history of preventive treatment failure: results from two global randomized clinical trials (2019) (21)
Vasodilator Agents and Supracollicular Transection Fail To Inhibit Cortical Spreading Depression in the Cat (1999) (21)
The ORL-1 (NOP1) receptor ligand nociceptin/orphanin FQ (N/OFQ) inhibits neurogenic dural vasodilatation in the rat (2002) (21)
Home-Based Trials in Adolescent Migraine: A Randomized Clinical Trial (2017) (21)
Systematic review of outcomes and endpoints in preventive migraine clinical trials (2021) (21)
28 – Migraine as a Cerebral Ionopathy with Impaired Central Sensory Processing (2007) (21)
Neuromodulatory approaches to the treatment of trigeminal autonomic cephalalgias. (2007) (21)
Sensory information processing may be neuroenergetically more demanding in migraine patients (2013) (21)
Medication-overuse headache in cluster headache patients (2004) (21)
MAP0004, orally inhaled dihydroergotamine for acute treatment of migraine: efficacy of early and late treatments. (2011) (21)
Acquired immunodeficiency syndrome (AIDS) and sulfadiazine-associated acute renal failure. (1987) (21)
The Role of Dopamine in a Model of Trigeminovascular Nociception (2005) (21)
Onset of efficacy and duration of response of galcanezumab for the prevention of episodic migraine: a post-hoc analysis (2019) (21)
Large Conductance Calcium-Activated Potassium Channels (BKCa) Modulate Trigeminovascular Nociceptive Transmission (2009) (21)
Occipital headaches and neuroimaging in children (2017) (21)
Evaluation and Proposal for Optimization of Neurophysiological Tests In Migraine: Part 2—Neuroimaging and The Nitroglycerin Test (2007) (21)
Occipital cortex and cerebellum gray matter changes in visual snow syndrome (2020) (21)
On the functional anatomy of migraine (1998) (20)
6-MERCAPTOPURINE-RELATED LEUCOPENIA AND IN VIVO XANTHINE OXIDASE ACTIVITY (1986) (20)
Neurogenic vasodilation of dural blood vessels is not mediated by cholinergic transmission in the anaesthetised rat. (2004) (20)
Chronic versus episodic migraine: The 15‐day threshold does not adequately reflect substantial differences in disability across the full spectrum of headache frequency (2021) (20)
Imaging the Premonitory Phase of Migraine (2020) (20)
Modulation of nociceptive dural input to the trigeminocervical complex through GluK1 kainate receptors (2015) (20)
Disrupted connectivity within visual, attentional and salience networks in the visual snow syndrome (2021) (20)
Safety and effi cacy of ALD 403 , an antibody to calcitonin gene-related peptide , for the prevention of frequent episodic migraine : a randomised , double-blind , placebo-controlled , exploratory phase 2 trial (2014) (20)
Migraine: diagnosis and management (2003) (20)
Brainstem activation of the adrenal medulla in the cat (1985) (20)
Neuroimaging of migraine (2006) (20)
Triptans attenuate capsaicin-induced CREB phosphorylation within the trigeminal nucleus caudalis: a mechanism to prevent central sensitization? (2011) (19)
Advances in the Pharmacotherapy of Migraine (1999) (19)
Bilateral Paroxysmal Hemicrania or Bilateral Paroxysmal Cephalalgia, Another Novel Indomethacin-Responsive Primary Headache Syndrome? (2005) (19)
Headache and non-headache symptoms provoked by nitroglycerin in migraineurs: A human pharmacological triggering study (2020) (19)
Long-term safety, tolerability, and efficacy of fremanezumab in migraine (2020) (19)
Familial SUNCT (2005) (19)
Basilar artery aneurysm with autonomic features: an interesting pathophysiological problem (2001) (19)
Cluster headache pathophysiology — insights from current and emerging treatments (2021) (19)
Experts’ opinion about the pediatric secondary headaches diagnostic criteria of the ICHD-3 beta (2017) (19)
Primary headache disorders Five new things (19)
Pathophysiology of headache (2008) (19)
Migraine triggers (2013) (18)
Treatment of hemicrania continua by non-invasive vagus nerve stimulation in 2 patients previously treated with occipital nerve stimulation (2013) (18)
Nitroglycerine triggers triptan-responsive cranial allodynia and trigeminal neuronal hypersensitivity (2018) (18)
Post-triptan era for the treatment of acute migraine (2004) (18)
Intravenous aspirin (lysine acetylsalicylate) in the inpatient management of headache (2010) (18)
Differential trigeminovascular nociceptive responses in the thalamus in the familial hemiplegic migraine 1 knock-in mouse: A Fos protein study (2014) (18)
Cluster Headache: New Perspectives (1999) (18)
The subcortical belly of sleep: New possibilities in neuromodulation of basal ganglia? (2020) (18)
Cough Headache Responsive To Methysergide (1998) (18)
Paroxysmal hemicrania responding to topiramate (2009) (18)
Immunoreactivity of NOS, CGRP, PACAP, SP and VIP in the trigeminal nucleus caudalis and in the cervical spinal cord C1 and C2 of the cat (2003) (18)
Systematic review of outcomes and endpoints in acute migraine clinical trials (2021) (18)
Pharmacological opportunities and pitfalls in the therapy of migraine (2001) (18)
Prioritizing treatment attributes and their impact on selecting an oral triptan: Results from the TRIPSTAR project (2004) (18)
Cerebral blood flow is not coupled to neuronal activity during stimulation of the facial nerve vasodilator system (1994) (18)
Gait and balance disorders (2002) (17)
Paroxysmal Hemicrania in a Family (2006) (17)
4991W93, a potent blocker of neurogenic plasma protein extravasation, inhibits trigeminal neurons at 5-hydroxytryptamine (5-HT1B/1D) agonist doses (2001) (17)
Lignocaine and headache: An electrophysiological study in the cat with supporting clinical observations in man (1994) (17)
Are some patient-perceived migraine triggers simply early manifestations of the attack? (2021) (17)
Exposure and isolation of the superior sagittal sinus elicits Fos in the trigeminal nucleus caudalis and dorsal horn of the cervical spinal cord: how long should you wait? (1999) (17)
Examination of the involvement of neuropeptide Y (NPY) in cerebral autoregulation using the novel NPY antagonist PP56 (1993) (17)
Erratum: Subcutaneous octreotide in cluster headache: Randomized placebo-controlled double-blind crossover study (Annals of Neurology (October 2004) 56 (488-494)) (2004) (17)
Acid‐sensing ion channel 3 blockade inhibits durovascular and nitric oxide‐mediated trigeminal pain (2020) (16)
Decade in review—migraine: Incredible progress for an era of better migraine care (2015) (16)
New directions in migraine research (2002) (16)
Stress, emotion and the heart: tako-tsubo cardiomyopathy (2006) (16)
Treatment preferences and the selection of acute migraine medications: results from a population-based survey (2004) (16)
Migraine and Structural Changes in the Brain (2013) (16)
Child Neurology: Migraine with aura in children (2010) (16)
Sphenopalatine (pterygopalatine) ganglion stimulation and cluster headache: New hope for ye who enter here (2013) (15)
Small-molecule CGRP receptor antagonists: A new approach to the acute and preventive treatment of migraine (2020) (15)
Functional Imaging in Chronic Migraine (2013) (15)
Primary headache disorders (2019) (15)
Comparative effects of traditional Chinese and Western migraine medicines in an animal model of nociceptive trigeminovascular activation (2017) (15)
Cyclic alternating pattern in obstructive sleep apnea: A preliminary study (2021) (15)
Migraine Is More Than Just Headache: Is the Link to Chronic Fatigue and Mood Disorders Simply Due to Shared Biological Systems? (2021) (15)
Phase 3, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of erenumab (amg 334) in migraine prevention: primary results of the strive trial (2017) (15)
Paroxysmal raised intracranial pressure associated with spinal meningeal cysts (2005) (15)
Randomized double-blind, placebo-controlled trial of high-flow inhaled oxygen in acute cluster headache (2007) (15)
Olvanil acts on transient receptor potential vanilloid channel 1 and cannabinoid receptors to modulate neuronal transmission in the trigeminovascular system (2012) (15)
Primary Sex Headache in Adolescents (2012) (15)
Posterior hypothalamic activation in paroxysmal hemicrania using PET (2005) (15)
Premonitory Symptoms of Migraine in Childhood and Adolescence (2017) (15)
Neuroimaging of migraine. (2006) (15)
Diagnosis and Optimum Treatment of Migraine (1994) (15)
Non-Invasive Vagus Nerve Stimulation (nVNS) for Acute Treatment of Migraine: An Open-Label Pilot Study (S40.004) (2013) (15)
Analysis of occipital nerve stimulation in studies of chronic migraine and broader implications of social media in clinical trials (2013) (15)
Time course of efficacy of ubrogepant for the acute treatment of migraine: Clinical implications (2020) (15)
Another migraine gene (2005) (14)
21st century headache: mapping new territory (2021) (14)
Migraine pathogenesis: Neural and vascular mechanisms (2003) (14)
Cluster Headache and Other Trigemino‐Autonomic Cephalgias (2010) (14)
Trigeminal Autonomic Cephalalgias (2012) (14)
Migraine Aura A Knockin Mouse with a Knockout Message (2004) (14)
Exacerbation of headache during dihydroergotamine for chronic migraine does not alter outcome (2016) (14)
Postoperative hemicrania continua-like headache - a case series (2015) (14)
Views and Perspectives Consensus Statement: Cardiovascular Safety Profile of Triptans (5-HT 1B/1D Agonists) in the Acute Treatment of Migraine (2004) (14)
Cluster headache and the trigeminal-autonomic reflex: Driving or being driven? (2018) (14)
Nitric oxide is not the sole determinant of hypercapnic or metabolically driven vasodilation in the cerebral circulation. (1994) (14)
Pediatric Migraine Prevention-First, Do No Harm. (2017) (14)
Sustained pain relief with dihydroergotamine in migraine is potentially due to persistent binding to 5-HT1B and 5-HT1D receptors (2012) (14)
Prolonged migraine aura: new insights from a prospective diary-aided study (2018) (13)
Pathophysiology of myotonia and periodic paralysis (2002) (13)
The Migraine Brain: Imaging Structure and Function (2012) (13)
Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura (2021) (13)
Paroxysmal sneezing after hypothalamic deep brain stimulation for cluster headache (2012) (13)
No relationship between vasoactive intestinal polypeptide expression and headache in pituitary tumours (2005) (13)
Discovery of CGRP in relation to migraine (2019) (13)
Response to: Migraine and Vertigo: A Marriage of Convenience? (2011) (13)
Evaluation of treatment response and symptom progression in 400 patients with visual snow syndrome (2021) (13)
Advances in the pharmacotherapy of migraine. How knowledge of pathophysiology is guiding drug development. (1999) (13)
Cost-Effectiveness of Erenumab for the Preventive Treatment of Migraine in Patients with Prior Treatment Failures in Sweden (2021) (13)
Viral diseases of the nervous system (2002) (13)
A multicentre, double-blind, placebo-controlled, dose-ranging study to investigate the efficacy and safety of oral doses dose of 311C90 in the acute treatment of migraine (1994) (13)
Topiramate is likely to act outside of the trigeminocervical complex (2013) (13)
Pathophysiology of nerve and root disorders (2002) (13)
Helospectin-Like Peptides: Immunochemical Localization and Effects on Isolated Cerebral Arteries and on Local Cerebral Blood Flow in the Cat (1999) (12)
Field-testing the criteria for "visual snow" (positive persistent visual disturbance) (2012) (12)
The Association Between Parental Migraine and Infant Colic: A Cross‐Sectional, Web‐Based, U.S. Survey Study (2019) (12)
Localised increase in regional cerebral perfusion in patients with visual snow syndrome: a pseudo-continuous arterial spin labelling study (2021) (12)
Pressor response to electrical and chemical stimulation of nucleus raphe dorsalis in the cat. (1985) (12)
Alterations in Functional Connectivity During Different Phases of the Triggered Migraine Attack (2020) (12)
High-Flow Oxygen for Treatment of Cluster Headache (2016) (12)
Bench to bedside: what have we learnt recently about headache? (1997) (12)
The utility of radioisotope cisternography in low CSF/volume syndromes compared to myelography (2016) (12)
The role of the periaqueductal gray (PAG) in the pathogenesis of migraine. (1999) (12)
The migraine postdrome: Spontaneous and triggered phenotypes (2021) (12)
Increased rate of venous thrombosis may be associated with inpatient dihydroergotamine treatment (2017) (12)
Efficacy of ubrogepant based on prior exposure and response to triptans: A post hoc analysis (2021) (12)
An interactive, readily transportable program using a log/logit transformation for the analysis of radioimmunoassay data. (1986) (12)
Neck-Tongue syndrome: A systematic review (2018) (12)
New Targets for Migraine Therapy (2014) (12)
The relationship between neuropeptide Y expression and headache in pituitary tumours (2006) (12)
Nociceptive‐specific blink reflex and glyceryl trinitrate infusion in healthy volunteers (2003) (12)
Exploding head syndrome, snapping of the brain or episodic cranial sensory shock? (2016) (12)
Health state utilities associated with attributes of migraine preventive treatments based on patient and general population preferences (2019) (12)
Cortical modulation of thalamic function during cortical spreading depression- Unraveling a new central mechanism involved in migraine aura" (2013) (11)
Psychiatric side effects during methysergide treatment (2005) (11)
Headache in three new cases of Harlequin syndrome with accompanying pharmacological comparison with migraine (2012) (11)
Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine (2021) (11)
Visual snow syndrome: a comparison between an Italian and British population (2020) (11)
Mechanistic Investigations Support Liver Safety of Ubrogepant (2020) (11)
The Migrainous Brain: What You See Is Not All You Get? (2006) (11)
Acetylsalicylic acid inhibits cerebral cortical vasodilatation caused by superior sagittal sinus stimulation in the cat * (1994) (11)
Increasing the options for effective migraine management (1997) (11)
The enigma of the interconnection of trigeminal pain and cranial autonomic symptoms (2016) (11)
[Physiopathology of migraine]. (1990) (11)
Migraine Therapy: Current Approaches and New Horizons (2018) (11)
THE PHENOTYPE OF PREMONITORY SYMPTOMS AND MIGRAINE HEADACHE TRIGGERED WITH NITROGLYCERIN (2016) (11)
Effect of erenumab on functional outcomes in patients with episodic migraine in whom 2–4 preventives were not useful: results from the LIBERTY study (2021) (11)
Is a central action of acute antimigraine drugs essential? (1997) (11)
Predictors of Triptan Response in Pediatric Migraine. (2016) (11)
Raeder's syndrome [corrected]: paratrigeminal paralysis of the oculopupillary sympathetic system. (2002) (11)
How do we fashion better trials for neurostimulator studies in migraine? (2013) (11)
Aprepitant for the management of nausea with inpatient IV dihydroergotamine (2016) (10)
Are Triptans with Enhanced Lipophilicity Used for the Acute Treatment of Migraine Associated with an Increased Consulting Rate for Depressive Illness? (2000) (10)
Guidance for the management of headache in sport on behalf of The Royal College of General Practitioners and The British Association for the Study of Headache (2011) (10)
Is migraine a progressive disorder? (2005) (10)
Pseudopseudohypoparathyroidism and spinal cord compression. (1991) (10)
Migraine: diagnosis and treatment (2018) (10)
N‐Methyl‐d‐aspartate receptor open‐channel blockers memantine and magnesium modulate nociceptive trigeminovascular neurotransmission in rats (2019) (10)
Randomized, Double-blind, Placebo-controlled Trial of ALD403, an anti-CGRP peptide antibody in the prevention of chronic migraine. (S52.003) (2017) (10)
Cluster headache in primary care: unmissable, underdiagnosed and undertreated. (2006) (10)
Stress and migraine (2014) (10)
Double-blind placebo-controlled trial of topiramate in SUNCT (2007) (10)
Treatment of miscellaneous idiopathic headache disorders (group 4 of the IHS classification) – Report of an EFNS task force (2011) (10)
Efficacy of erenumab in subjects with episodic migraine with prior preventive treatment failure(s) (2017) (10)
What is the Physiological Role of The Trigemino-Vascular System? (1995) (10)
New Generation Gepants: Migraine Acute and Preventive Medications (2022) (10)
A prospective clinical study with diagnostic implications (2002) (10)
Electrical stimulation of the fastigial nucleus increases total cerebral blood flow in the monkey (1989) (10)
Diseases of the nervous system: clinical neuroscience and therapeutic principles (2002) (10)
Cluster headache: focus on emerging therapies (2004) (10)
A trans-cultural comparison of the organisation of care at headache centres world-wide (2011) (10)
Differential actions of indomethacin: clinical relevance in headache (2020) (10)
Somatostatin infusion withdrawal: a study of patients with migraine, cluster headache and healthy volunteers (2003) (9)
Synthesis of cluster headache pathophysiology (2006) (9)
Was it something I ate? Understanding the bidirectional interaction of migraine and appetite neural circuits (2021) (9)
Enhancing cognitive-behavioural therapy for recurrent headache: design of a randomised controlled trial (2014) (9)
Functional MRI in SUNCT (Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing) and SUNA (Short-lasting Unilateral Neuralgiform headache attacks with cranial Autonomic symptoms) shows differential hypothalamic activation with increasing pain (2006) (9)
Biochemical Modulation and Pathophysiology of Migraine. (2019) (9)
Extracerebral Levels of Circulating Vasoactive Peptides during Migraine Headache (1989) (9)
Trigeminal autonomic cephalalgias presenting in a multidisciplinary tertiary orofacial pain clinic (2019) (9)
Safety of domperidone in treating nausea associated with dihydroergotamine infusion and headache (2016) (9)
The oligemic phase of cortical spreading depression is not blocked by tirilazad mesylate (U-74006F) (1992) (9)
CNQX inhibits trigeminovascular neurons in the rat: a microiontophoresis study (2006) (9)
Two-year efficacy and safety of erenumab in participants with episodic migraine and 2–4 prior preventive treatment failures: results from the LIBERTY study (2021) (9)
Comprehensive clinical phenotyping of nitroglycerin infusion induced cluster headache attacks (2021) (9)
Trigeminal Autonomic Cephalalgias in Children and Adolescents: Cluster Headache and Related Conditions. (2016) (9)
Extrinsic Innervation: Transmitters, Receptors, and Functions—The Sympathetic Nervous System (1997) (9)
Chirp stimulation: H-response short and dynamic (2014) (9)
Migraine: a brain state amenable to therapy (2019) (9)
Hereditary juvenile parkinsonism with pyramidal signs and mental retardation (1995) (8)
Cervicogenic headache: a pain in the neck for some neurologists? (2009) (8)
Patophysiology of headache (2001) (8)
Trigeminal-autonomic cephalgias (TACs) (1998) (8)
Nitroglycerine triggers triptan-responsive cranial allodynia and trigeminal neuronal hypersensitivity. (2019) (8)
Economic evaluations in migraine: systematic literature review and a novel approach (2020) (8)
Integrating headache trigger management strategies into cognitive-behavioral therapy: A randomized controlled trial. (2021) (8)
Indomethacin‐responsive headaches—A narrative review (2021) (8)
Visual snow syndrome: is it normal or a disorder – and what to do with patients? (2020) (8)
A Novel Translational Animal Model of Trigeminal Autonomic Cephalalgias (2015) (8)
The Migraine Postdrome (2018) (8)
Central neuromodulation with implanted suboccipital stimulators in patients with chronic migraine (2003) (8)
Long-term Efficacy and Safety of Erenumab (2021) (8)
Cocaine abuse simulating the aura of migraine. (1992) (8)
Recent Neuroimaging Advances in the Study of Primary Headaches (2015) (8)
A Multicenter, Prospective, Single Arm, Open Label, Post-Market, Observational Study to evaluate the use of sTMS in reduction of Migraine Headache (ESPOUSE Study) (S52.004) (2017) (8)
Cluster headaches: introduction and epidemiology (2006) (8)
Rizatriptan in Acute Treatment of Migraine: Update on New Comparative Data∗ (2000) (8)
Almotriptan and zolmitriptan in the acute treatment of migraine (2007) (8)
Vertigo and vestibular disorders (2002) (8)
Therapeutic targeting of nitroglycerin-mediated trigeminovascular neuronal hypersensitivity predicts clinical outcomes of migraine abortives. (2020) (8)
Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: findings from the randomised, double-blind, sham-controlled ACT2 study (2017) (7)
Increased urinary excretion of nitric oxide metabolites in longitudinally monitored migraine patients (2006) (7)
Prevention of Episodic Migraine with AMG 334, a Human Anti-Calcitonin Gene-Related Peptide Receptor Monoclonal Antibody: Phase 2 Study Results and 52-Week Analysis of Open-Label Extension (S26.002) (2016) (7)
Putting migraine to sleep: Rexants as a preventive strategy (2015) (7)
EHMTI-0178. CGRP monoclonal antibody LY2951742 for the prevention of migraine: a phase 2, randomized, double-blind, placebo-controlled study (2014) (7)
Disorders of intracranial pressure (2002) (7)
Oculomotor control: normal and abnormal (2002) (7)
Sustained Efficacy and Long-term Safety of Erenumab in Patients with Episodic Migraine: 4+ Year Results of a 5-year, Open-label Treatment Period (1203) (2020) (7)
Extracranial Peptide Release following Stimulation of the Superior Sagittal Sinus in the Cat (1989) (7)
Unique Migraine Subtypes, Rare Headache Disorders, and Other Disturbances (2015) (7)
CGRP pathway monoclonal antibodies for cluster headache (2020) (7)
Targets for migraine treatment: beyond calcitonin gene-related peptide (2021) (7)
What is the physiological role of the trigeminovascular system? (1995) (7)
Characterization of opioidergic mechanisms related to the anti-migraine effect of vagus nerve stimulation (2021) (7)
Understanding migraine in women. (2002) (6)
Primary cough headache treated with non-invasive vagal nerve stimulation (2020) (6)
Autoregulation and autonomic control of the cerebral circulation: implications and pathophysiology (1998) (6)
Animal models of headache (2006) (6)
Neuropeptides and Migraine-A Useful Biological Marker? (1995) (6)
Post market pilot programme with single pulse transcranial magnetic stimulation (sTMS) for acute treatment of migraine: SpringTMS™ use in migraine (2013) (6)
Nociception-specific blink reflex: pharmacology in healthy volunteers (2015) (6)
Response to "Therapeutic gain: A critique" (1999) (6)
Emergence of Pituitary Adenoma in a Child during Surveillance: Clinical Challenges and the Family Members' View in an AIP Mutation-Positive Family (2018) (6)
Noncholinergic, nonadrenergic cortical vasodilatation elicited by thalamic centromedian-parafascicular complex. (1993) (6)
Phenotypic characterisation of the headache associated with pituitary tumours (2003) (6)
Question & answer session. (2009) (6)
Migraine with cranial autonomic features following surgically induced post‐ganglionic sympathetic lesion (2014) (6)
Multinational descriptive analysis of the real‐world burden of headache using the Migraine Buddy application (2021) (6)
Primary neurovascular headache (2006) (6)
Phenotype of patients responding to sub-occipital neurostimulation for refractory head pain (2008) (6)
Co-activation of rhythms during alpha band oscillations as an interictal biomarker of exploding head syndrome (2020) (6)
Cranial autonomic symptoms: prevalence, phenotype and laterality in migraine and two potentially new symptoms (2021) (6)
Case Report: Transformation of Visual Snow Syndrome From Episodic to Chronic Associated With Acute Cerebellar Infarct (2022) (6)
Is migraine a progressive disorder? Considering the clinical implications of new research data on migraine and brain lesions. (2005) (6)
Motor neuron disease (2002) (6)
Perivascular Peptide Transmitters: Innervation and Release in Migraine (1989) (6)
Neuronal nitric oxide synthase regulates regional brain perfusion in healthy humans (2021) (6)
Sudden unilateral neuralgiform pain with conjunctival injection and tearing (2006) (6)
Clinical features of human prion diseases (2002) (5)
Prevention and treatment of cluster headache (2009) (5)
Cluster Headache and Calcitonin Gene-Related Peptide-More on Quantum Therapeutics in Headache Medicine. (2018) (5)
Candesartan in migraine prevention: results from a retrospective real-world study (2020) (5)
1557 Alterations in cerebral blood flow during the postdrome phase of a migraine attack captured with arterial spin labelled (asl) mri (2017) (5)
Clinical characterization of "visual snow" (Positive Persistent Visual Disturbance) (2013) (5)
Predicting the response to a triptan in migraine using deep attack phenotyping: A feasibility study (2020) (5)
A simple method, using 2-hydroxypropyl-beta-cyclodextrin, of administering alpha-chloralose at room temperature. (1997) (5)
Refractory Migraine and Chronic Migraine: Pathophysiological Mechanisms (2008) (5)
Natural course of visual snow syndrome: a long-term follow-up study (2022) (5)
International Headache Society abstracts (2015) (5)
Reduced expression of calcitonin gene related peptide in mice with the familial hemiplegic migraine (FHM) 1 mutation (2007) (5)
Cluster Headache in Kuwait: A Hospital-Based Study (2019) (5)
Emerging oral triptan therapies (1999) (5)
Migraine and Sleep: New Connections (2013) (5)
Transcranial Magnetic Stimulation Inhibits Cortical Spreading Depression but Not Trigeminocervical Activation in Animal Models of Migraine (2010) (5)
Emerging Targets for Migraine Treatment. (2021) (5)
Acetaminophen in the Treatment of Headache: A Cannabinoid Agonist within the Trigeminovascular System (2011) (5)
Eptinezumab for the preventive treatment of migraine. (2020) (5)
The selective 5‐HT1F receptor agonist lasmiditan inhibits trigeminal nociceptive processing: Implications for migraine and cluster headache (2021) (5)
Challenges and complexities in designing cluster headache prevention clinical trials: A narrative review (2022) (5)
Emerging Treatment Options for Migraine. (2018) (5)
Measurement of neurological outcomes (2002) (5)
Post‐vaccination headache reporting: Trends according to the Vaccine Adverse Events Reporting System (2016) (5)
Overview of Trigeminal Autonomic Cephalalgias: Nosologic Evolution, Diagnosis, and Management (2018) (5)
Low CSF Volume (Pressure) Headache (2002) (5)
All that is obvious is not clear: What is the origin of throbbing pain in migraine? (2013) (5)
Visual Snow: A New Disease Entity Distinct from Migraine Aura (S36.006) (2012) (5)
Restricted truncal sagittal movements of rapid eye movement behaviour disorder (2022) (4)
Efficacy of Erenumab for the Treatment of Patients With Chronic Migraine With and Without Aura (S32.006) (2018) (4)
Disorders of neuromuscular junction transmission (2002) (4)
Squeezing life into botulinum toxin A in migraine: Imploding versus Exploding Pain (2006) (4)
Cluster headache: Update on a common neurological problem (2001) (4)
Migraine Misdiagnosed as Idiopathic Intracranial Hypertension (2011) (4)
Attention deficit hyperactivity disorder: spectrum and mechanisms (2002) (4)
Neurological consequences of drug abuse (2002) (4)
Erenumab in chronic migraine: Experience from a UK tertiary centre and comparison with other real‐world evidence (2022) (4)
Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain vs Moderate or Severe Pain (2022) (4)
Cortical Spreading Depression-Evoked Discharges on Trigeminothalamic Neurons (2012) (4)
Short-lasting, unilateral, neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) syndrome (2005) (4)
MUMS the word. Migraine with unilateral motor symptoms: what can you say? (2007) (4)
Functional neuroimaging of primary headache disorders (2005) (4)
Calcitonin gene-related peptide (CGRP): a molecular link between obesity and migraine? (2010) (4)
Subcutaneous octreotide is effective in the treatment of acute cluster headache: a double-blind placebo-controlled crossover study (2003) (4)
Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) (2014) (4)
THE CHANGING FACE OF CHRONIC MIGRAINE: WHO TO TREAT, HOW TO TREAT? (2010) (4)
Repeat expansion and neurological disease (2002) (4)
GABA(A) Receptors in the Nucleus Raphe Magnus Modulate Trigeminal Cell Firing Responsive to Activation of Craniovascular and Dural Afferents (2012) (4)
Evaluating the clinical utility of the patient‐identified most bothersome symptom measure from PROMISE‐2 for research in migraine prevention (2022) (4)
Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review (2023) (4)
Sporadic hemiplegic migraine (2003) (4)
Aneurysms and arteriovenous malformations (2002) (4)
Perceptions, experiences, and understandings of cluster headache among GPs and neurologists: a qualitative study. (2020) (4)
Managing the patient with migraine. (2001) (4)
Evolving options for the treatment of cluster headache. (2020) (4)
Predicting treatment response to candesartan in migraine patients (2017) (4)
Developing Common Data Elements (CDEs) for headache clinical research: A National Institute of Neurological Disorders and Stroke (NINDS), NIH initiative (2012) (4)
Spontaneous intracranial hypotension, hygromata and haematomata (2008) (4)
GABAA receptors in the nucleus raphe magnus modulate firing of neurons in the trigeminocervical complex (2013) (4)
Giant cell arteritis and ophthalmoplegia. (1991) (4)
Headache associated with acute substance use or exposure (1997) (4)
Topiramate for migraine prevention in fertile women: Reproductive counseling is warranted (2014) (4)
A Report on the Journal (2003) (4)
Imaging the premonitory phase of migraine - new insights into generation of the migraine attack (2013) (4)
The Hemicrania Continua Diagnosis (2002) (4)
Inhibition of trigeminal neurons after intravenous administration of naratriptan through an action at 5-hydroxytriptamine (5-HT_ ) receptor (1997) (4)
Dilatation in the carotid vascular territory of the cat in response to activation of cell bodies in the locus coeruleus. (1984) (4)
Familial paroxysmal hemicrania (2004) (4)
EHMTI-0186. Multi-center 3T MRI study of cortical thickness abnormalities in migraine (2014) (3)
James W. Lance MD. (2019) (3)
Principles of pharmacotherapy of the epilepsies (2002) (3)
Cluster Headache (2001) (3)
Recent Advances in the Management of Cluster Headache (2020) (3)
Site of effect of LY2951742 for migraine prophylaxis–Authors' reply (2015) (3)
Headache (chronic tension-type). (2003) (3)
Treatment of Acute Migraine Attacks with Naratriptan (2000) (3)
Topiramate Acts on Kainate Receptors within the Trigeminothalamic Pathway (2010) (3)
Blunted Trigeminovascular Nociceptive Responses in Mice with the CACNA1A Mutation (2010) (3)
The neurobiology of drug addition (2002) (3)
Spontaneous intracranial hypotension, hygromata and haematomata (2009) (3)
Basic Science: Prejunctional and Presynaptic Trigeminovascular Targets: What Preclinical Evidence Is There? (2004) (3)
Migraine is common in patients with sarcoidosis (2018) (3)
[Pathophysiology and treatment of trigeminal autonomic cephalalgias]. (2008) (3)
EKG changes associated with the use of veraparnil in cluster headache (2006) (3)
14th International Headache Congress: Basic Science Highlights (2010) (3)
Migraine Management: Contrasting Patient Preferences With Current Clinical End Points: Introduction (2002) (3)
Peripheral brain-derived neurotrophic factor (BDNF) in insomnia: A systematic review and meta-analysis. (2022) (3)
Sumatriptan is not the only analgesic used inappropriately (1998) (3)
Headache attributed to head or neck trauma (2008) (3)
Migraine‐Like Features in Cluster Headache (2014) (3)
Nitroglycerine triggers triptan-responsive cranial allodynia and trigeminal neuronal hypersensitivity. (2019) (3)
Eating disorders: neurobiology and symptomatology (2002) (3)
Nociception-specific blink reflex: a double-blinded placebo-controlled pharmacological study in 21 healthy males (2007) (3)
Altered Responses in the Descending Modulatory System of Transgenic Mice with a CACNA1A Mutation (2010) (3)
International Headache Society classification of trigeminal autonomic cephalgias (TACs) (1999) (3)
Potential new drugs for acute and prophylactic treatment of migraines (2006) (3)
Verapamil and lymphomatoid papulosis in chronic cluster headache (2004) (3)
Migraine among medical students in (2014) (3)
Massive benign thymoma presenting as ocular myasthenia. (1989) (3)
EHMTI-0237. The A11 hypothalamic nucleus is susceptible to nitric oxide signalling (2014) (3)
Zolmitriptan in the acute treatment of migraine: An overview (2000) (3)
Metabolic Activity and Blood Flow in the Caudal Medulla and Upper Cervical Spinal Cord of the Cat during Stimulation of the Superior Sagittal Sinus (1989) (3)
Autonomic function and dysfunction (2002) (3)
Biomarkers in Migraine — Glimpses into the Future (2006) (3)
Understanding Migraine Pathophysiology Through Studying the Mechanism of Action of Rizatriptan (1999) (3)
Triptan signal transduction (2006) (3)
Sumatriptan and giant cell arteritis. (1994) (3)
EHMTI-0287. Peptides involved in sleep and appetite homeostatic regulation and its effects in the modulation of trigeminovascular nociceptive activation (2014) (3)
The effect of infusion of various peptide antisera on vasodilatation in the cat common carotid vascular territory. (1985) (3)
75% responder rates provide improvement in HIT-6 scores from week 4 through 12 following a single infusion of ALD403, or placebo. (P2.165) (2017) (3)
Routes of Administration of Acute Migraine Therapy (1999) (3)
Last Minute Oral And Poster Presentations XI: Congress of the International Headache Society/IHC 2003 Rome, Italy 3-16 September 2003 (2004) (3)
The discovery and development of inhaled therapeutics for migraine (2019) (3)
Onset of cluster headache triggered by emotional effect: a case report (2006) (3)
Evidence for hypothalamic activation in cluster headache (1999) (3)
Primary brain tumours in adults (2002) (3)
Case Report of the Safety Assessment of Transcranial Magnetic Stimulation Use in a Patient With Cardiac Pacemaker: To Pulse or Not to Pulse? (2018) (2)
Co-localization of substance P and calcitonin gene-related peptide with Fos labelling in the trigeminal cervical complex after superior sagittal sinus stimulation (2004) (2)
The Role of Noninvasive Neuromodulation in Migraine Management (2016) (2)
Host responses in central nervous system infection (2002) (2)
Migraine—Some Theories and Controversies (2012) (2)
Migraine treatment and mistreatment: primum non nocere (2000) (2)
Dual Orexin Receptor Antagonists Inhibit Nociceptive Neuronal Activity in the Trigeminocervical Complex of the Rat (S55.006) (2013) (2)
Mapping the Brain in Primary Headache Disorders (2015) (2)
Surgical Treatment of Chronic Cluster Headache (2003) (2)
Medically unexplained symptoms: (Letter 2 of 5) (2003) (2)
O010. Migraine aura symptoms last for more than one hour in more than one quarter of patients: results from a prospective diary-aided study (2015) (2)
The Inhibiting Effects of the TRPV1 Agonist Olvanil Are Not Exclusively Mediated by the TRPV1 Channel (2011) (2)
Abnormal Blink Reflex Studies in a Patient With Supraorbital Neuralgia (2006) (2)
Sodium valproate but not gabapentin modulates trigeminovascular nociceptive transmission in the thalamus via GABA(A) receptor mechanisms: implications for migraine (2009) (2)
Comment: How do triptans work in migraine? (2015) (2)
EHMTI-0379. Update of the uk post market pilot programme with single pulse transcranial magnetic stimulation (STMS) for the acute treatment of migraine (2014) (2)
Author's reply on Pathophysiology of migraine (2013) (2)
Brain structural and neurometabolic correlates of visual snow disorder (P1.291) (2015) (2)
Hemiplegic Migraine and Channel Disorders (2009) (2)
EHMTI-0357. Perceptions and experiences of cluster headache among patients, general practitioners and neurologists in the north of england: a qualitative study (2014) (2)
Pituitary tumours and headache:does size matter (2008) (2)
Magnesium and memantine do not inhibit nociceptive neuronal activity in the trigeminocervical complex of the rat (2013) (2)
Genetics of common neurological disorders (2002) (2)
Intravenous lidocaine is effective in the treatment of SUNCT syndrome (2003) (2)
Epidemiology and impact of headache disorders (2018) (2)
Comparison and predictors of chronic migraine vs. new daily persistent headache presenting with a chronic migraine phenotype (2022) (2)
Medical Comorbidities of Migraine: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study (P3.133) (2018) (2)
KCl-induced repetitive cortical spreading depression inhibits trigeminal neuronal firing mediated by 5-HT1B/1D and opioid receptor (2013) (2)
Author response: Migraine progression in subgroups of migraine based on comorbidities: Results of the CaMEO Study (2020) (2)
Encyclopedia of pain, vol. 1-3 (2007) (2)
Modulation of trigeminovascular activity by leptin: a novel antinociceptive mechanism? (2013) (2)
Vasoactive peptides and the carcinoid syndrome. (1988) (2)
5.33 – Migraine – A Disorder Involving Trigeminal Brainstem Mechanisms (2008) (2)
Newer triptans: emphasis on rizatriptan. (2000) (2)
Calcitonin gene-related peptide receptor antagonists and triptans (2010) (2)
Headache in a Patient With Crowned Dens: Report of a New Case (2014) (2)
14 mmHg: a case of raised intracranial pressure? (2004) (2)
Pathophysiology and Therapy of Associated Features of Migraine (2022) (2)
Herbalism helps headache. (2012) (2)
Autism and autistic spectrum disorders (2002) (2)
The basis of immunotherapy in neurological disease (2002) (2)
Headache: Treatment update (2022) (2)
The last two years (2013) (2)
Hemicrania continua: A case series of forty patients (2008) (2)
096 Assessment of the efficacy of erenumab during the open-label treatment (13–24 weeks) of subjects with episodic migraine who failed 2–4 prior preventive treatments: results of the LIBERTY study (2019) (2)
Neurological manifestations of HIV infection (2002) (1)
New onset migraine with aura after treatment initiation with ivabradine (2013) (1)
Trigeminal Autonomic Cephalalgias (TACs) – Cluster Headache (2014) (1)
Intranasal Zolmitriptan Is Effective and Well Tolerated in Acute Cluster Headache: A Randomized Placebo-Controlled Double-Blind Crossover Study (2008) (1)
Reply (2002) (1)
Multidisciplinary headache clinic-impact of a new model for headache care in Dubai (2021) (1)
Emerging drugs for the prevention of migraine (2021) (1)
Development of new or worsening headache after cochlear implant activation: A hypothesis-generating pilot study of incidence, timing, and clinical factors (2020) (1)
Preventive Therapies for Chronic Migraine. (2018) (1)
Postural Headache and Cerebrospinal Fluid Leak: Believing Is Seeing (2003) (1)
Headache research in 2020: disrupting and improving practice (2021) (1)
Hemicrania continua--building on experience and clinical science. (2014) (1)
Dr James Lance, Professor of Neurology in Sydney, Australia, died on 20 February 2019, age 92 (2019) (1)
an algorithmic approach. (Jefferson Headache Center, Thomas Jefferson University, Philadelphia, PA) Neurology 2000;55:S46–S52. (2001) (1)
Migraine: beyond pain (2021) (1)
The migraine attack (2008) (1)
EHMTI-0111. Intra-variability of migraine attacks features (2014) (1)
Dim the Lights: A Narrative Review of Photophobia in Migraine (2022) (1)
Efficacy, safety and indirect comparisons of lasmiditan, rimegepant, and ubrogepant for the acute treatment of migraine: A systematic review and network meta-analysis of the literature. (2023) (1)
Neurological aspects of pregnancy (2002) (1)
Premonitory-like symptomatology in migraine (2017) (1)
Eptinezumab improved patient‐reported outcomes and quality of life in patients with migraine and prior preventive treatment failures (2022) (1)
Melatonin for Adolescent Migraine Prevention: A Pilot Internet-based Randomized Controlled Trial (P2.163) (2017) (1)
Inflammation in migraine…or not…: A critical evaluation of the evidence. (2021) (1)
Comprar Headache A Practical Manual | David Kernick | 9780199232598 | Oxford University Press (2008) (1)
Same-Day Bilateral Decubitus CT Myelography for Detecting CSF-Venous Fistulas in Spontaneous Intracranial Hypotension (2022) (1)
Trigeminal Autonomic Cephalalgias (TACs) – SUNCT/SUNA (2014) (1)
Immune mechanisms in neurological disease (2002) (1)
Psychiatric side effects during methysergide treatment. (2005) (1)
Genetically engineered models of neurodegenerative diseases (2002) (1)
The Bárány Society position on ‘Cervical Dizziness’ (2022) (1)
Migraine with Aura Phenomenology and Length (2014) (1)
Effect of IL-1β microinjection into the posterior hypothalamic area on trigeminal nociception in the rat (2003) (1)
New targets in acute migraine treatment (2006) (1)
Therapeutic gain or therapeutic ratio? (2003) (1)
Brain tumours in children (2002) (1)
Comment: Noninvasive neurostimulation for migraine should be part of the general neurologist's therapeutic armamentarium (2018) (1)
Tension-type headache: diagnosis and treatment (2018) (1)
Assessment of the Efficacy of Erenumab During the Open-Label Treatment (13–24 Weeks) of Subjects with Episodic Migraine Who Failed 2–4 Prior Preventive Treatments: Results of the LIBERTY Study (P1.10-002) (2019) (1)
The dopaminergic A11 cell group inhibits nociceptive transmission in the trigeminal nucleus caudalis (2006) (1)
Neuroimaging in trigeminal autonomic cephalgias (2006) (1)
The Ca2+-activated K+ (Maxik/Bk-ca) channel opener ns1619 is able to inhibit trigeminovascular activation both peripherally and centrally in the rat (2006) (1)
Myelination, demyelination and remyelination (2002) (1)
Acid-sensing ion channel 1-A potential site of action of amiloride in migraine with aura (2010) (1)
Cerebral Circulation: Autonomic Influences (2004) (1)
Author response: Safety of domperidone in treating nausea associated with dihydroergotamine infusion and headache (2017) (1)
Pharmacological modulation of ventral tegmental area neurons elicits changes in trigeminovascular sensory processing and is accompanied by glycemic changes: Implications for migraine (2022) (1)
Hemicrania continua- Major Shortcomings in the new classification or rigid thinking is death to progress (2014) (1)
Diagnosis and management of low back pain (2002) (1)
CHAPTER 59 – TRIGEMINAL AUTONOMIC CEPHALALGIAS: CLUSTER HEADACHE AND RELATED CONDITIONS (2007) (1)
The Relationship between Pain, Psychiatric, and Endocrine/Neurological Comorbidities of Migraine: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study (P3.124) (2018) (1)
Human brain–gut interactions: mechanisms of swallowing, visceral perception, and anal continence in health and disease (2002) (1)
An Inpatient Course Of Intravenous Dihydroergotamine Use For New Daily Persistent Headache (P7.180) (2014) (1)
New Oral Drugs for Migraine (2022) (1)
Chapter 20 – Vasoactive Peptides in Migraine and Cluster Headache (1993) (1)
Somatostatin inhibits the release of Ghrelin in normal subjects (2002) (1)
Exploding head syndrome: a co-activation of alpha-frequency band oscillations as a novel interictal fingerprint? (2017) (1)
Multi-Center 3T MRI Study of Thalamic Morphology in Migraine Using Label-Fusion-Based Segmentation and Deformation Based Morphometric Surface Analysis (S32.003) (2014) (1)
Mechanisms of motor control (2002) (1)
Headache in Primary Care (2000) (1)
Diseases of the vertebral column (2002) (1)
Infant Colic Is Associated with Maternal Migraine (S36.005) (2012) (1)
Release Of Vasoactive Peptides From The Trigeminovascular System Of Man And Cat (1987) (1)
Treatment of Miscellaneous Idiopathic Headache Disorders (2011) (1)
Extrinsic InnervationTransmitters, Receptors, and Functions—The Parasympathetic Nervous System (1997) (1)
PO069 Clinical characterisation of visual snow (2017) (1)
Extrinsic InnervationTransmitters, Receptors, and Functions—The Sympathetic Nervous System (1997) (1)
Epilepsy surgery: disease treatment and investigative opportunity (2002) (1)
Triptan medications to treat acute migraine (2002) (1)
Alopecia as an emerging adverse event to CGRP monoclonal antibodies: Cases Series, evaluation of FAERS, and literature review (2023) (1)
O011. Patients with “prolonged aura” do not show clinical or demographic differences from the patients with “typical aura” (2015) (1)
Other extrapyramidal syndromes: parkinsonism-plus and other forms of secondary parkinsonism (2002) (1)
Vasculitis of the central nervous system (2002) (1)
Subcutaneous sumatriptan and the migraine aura (1996) (1)
Prolactinoma and dopamine-agonist induced headache (2002) (1)
A Prospective Real-World Study Exploring Associations Between Passively Collected Tracker Data and Headache Burden Among Individuals with Tension-Type Headache and Migraine (2021) (1)
The CK1δ T44A Mutation Affects Nociceptive Activation of the Trigeminocervical Complex in an In Vivo Model of Migraine (P1.258) (2014) (1)
Migraine: nonvascular/neurally acting drugs as novel treatment strategies (2006) (1)
Migraine: Selecting Treatments now and Making Requests for the Future? (2001) (1)
Extrinsic innervation: transmitters, receptors, and functions - the trigeminovascular system (1997) (1)
Pathophysiology of nervous system diseases (2002) (1)
Migraine: diagnosis and optimum treatment (1994) (1)
Teaching NeuroImages: Greater occipital nerve injection (2019) (1)
Ictal Lack of Binding of [11C]-Dihydroergotamine to Brain Parenchyma Suggests That the Blood-Brain Barrier Remains Intact during Migraine Attacks (S32.002) (2014) (1)
Medically Unexplained Symptoms (2003) (1)
Drug Treatment of Migraine (2010) (1)
Leber's optic atrophy and “rhodanese” activity (1988) (1)
Chapter 1 – Migraine (2003) (1)
Sumatriptan and migraine : Breakthrough therapy? (1992) (1)
Re: Placebo responses in device studies (2018) (1)
To Our Reviewers (2002) (1)
Cluster headache, other trigeminal autonomic syndromes and the short-lived headaches (2002) (1)
Brain hemorrhage: Clinical high-risk factors for subarachnoid hemorrhage (2011) (1)
Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial (2023) (1)
Headache: a good year for research (2006) (1)
Testing rimegepant for migraine—time to revise the trial design? – Authors' reply (2020) (1)
The genetics of common epilepsies: common or distinct? In The Lancet Neurology, the International League Against Epilepsy Consortium on Complex Epilepsies (2014) (1)
The need for continued care after sponsor closure – Authors' reply (2020) (1)
Biomarkers of Migraine and Cluster Headache: Differences and Similarities (2022) (1)
Chapter 14. Cluster Headache (2008) (0)
Congenital disorders of cerebral cortical development (2002) (0)
Headache After Vaccination: An Update on Recent Clinical Trials and Real-World Reporting (2022) (0)
Author response: Gray matter volume modifications in migraine: A cross-sectional and longitudinal study (2019) (0)
High-Flow Oxygen for Cluster Headache—Reply (2010) (0)
Acquired disorders of language (2002) (0)
2005 Round-up (2006) (0)
Efficacy of Ubrogepant for the Treatment of Migraine Symptoms During the Prodrome (Premonitory Phase): Results From the PRODROME Trial (S47.002) (2023) (0)
Prostaglandin E2 injected into the posterior hypothalamus has no effect on trigeminal nociception in the rat (2003) (0)
Recent Advances and Updates in Trigeminal Autonomic Cephalalgias. (2022) (0)
PO068 The similarities between spontaneous and nitroglycerin-triggered premonitory symptoms in migraineurs (2017) (0)
Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy (2018) (0)
Editorial introductions. (2018) (0)
Patient‐reported experiences with migraine‐related cognitive symptoms: Results of the MiCOAS qualitative study (2023) (0)
Re: Donnan GA, Davis SM 'Neurology: reflections on the past millennium as we enter the next", Journal of Clinical Neuroscience 2000;7:1-2. (2000) (0)
Use of Oral Aprepitant for the Management of Nausea with Inpatient Intravenous Dihydroergotamine (DHE) Use (S40.006) (2013) (0)
Ubrogepant for the Acute Treatment of Migraine When Administered During the Prodrome (Premonitory Phase): Results From a Phase 3, Randomized, Double-blind, Placebo-Controlled, Crossover Study (S47.001) (2023) (0)
Efficacy of rimegepant for the acute treatment of migraine based on triptan treatment experience: Pooled results from three phase 3 randomized clinical trials (2023) (0)
A classification based on pathophysiology is a useful aid to differential diagnosis and effective treatment planning (2005) (0)
Nitroglycerin triggers triptan-responsive cranial allodynia and trigeminal neuronal hypersensitivity: Triptan-responsive cranial allodynia (2018) (0)
Cefalea neurovascular primaria (2006) (0)
Other secondary headaches (2008) (0)
Low-Threshold Inputs Responses of Dorsal Horn Neurons With High- and Hypothalamus Are Selective for the Nociceptive Inhibitory Effects Evoked From the Anterior (2015) (0)
The aging brain: morphology, imaging and function (2002) (0)
Spinal cord injury and repair (2002) (0)
Headache in the elderly (2008) (0)
Randomized Trial High-Flow Oxygen for Treatment of Cluster Headache: A (2009) (0)
P166 Flunarizine for paediatric headache: a ten year review (2009) (0)
Trigeminal autonomic cephalgias II-(paroxysmal hemicranla and SUNCT) and other short-lasting headache (hypnic headache) (2018) (0)
PAG P/Q-type calcium channel blockade facilitates trigeminal activity and does not affect GABA-mediated inhibition of trigeminal neurons (2001) (0)
Nonopiod peptides in migraine and cluster headache (1997) (0)
Post-traumatic headache (2018) (0)
EHMTI-0079. Reduced volume of anterior thalamic nuclei in migraineurs (2014) (0)
EHMTI-0039. Different efficacy of acute migraine therapies for migraine with aura versus without aura (2014) (0)
Areas of cerebral blood flow changes on arterial spin labelling with the use of symmetric template during nitroglycerin triggered cluster headache attacks (2021) (0)
Migraine Pathogenesis and Treatment (2011) (0)
Sleep in space (2018) (0)
Reply: Migraine: Preventive Treatment (2004) (0)
Migraine: preventive treatment. Authors' reply (2004) (0)
68 MIGRAINE: WHAT CAUSES THE HEADACHE AND ASSOCIATED SYMPTOMS? (2006) (0)
Cluster headache: causes and current approaches to treatment (2005) (0)
Functional neuroanatomy of the trigeminovascular system (1998) (0)
Headache and facial pain (2020) (0)
Therapeuticpotentialofnovel glutamatereceptorantagonists inmigraine (2009) (0)
Hereditary causes of stroke (2002) (0)
Response to ‘Do different treatment strategies of galcanezumab have similar effect on migraine?’ (2020) (0)
Letters to the Editor (2000) (0)
Abstracts of the VI International Congress on Headache in Children and Adolescents (2004) (0)
Reader Response: Clinical Characterization of Delayed Alcohol-Induced Headache: A Study of 1,108 Participants (2021) (0)
Randomised Controlled Trials (2000) (0)
Headache recurrence: what is it and how can it be managed? (1999) (0)
Headache associated with central nervous system infection (2018) (0)
Reply to Spierings (2000) (0)
Retraction. Psychiatric side effects during methysergide treatment. (2010) (0)
More on Calcitonin Gene-Related Peptide and Migraine Prevention (2015) (0)
The Role of Calcitonin Gene-Related Peptide in Neurally Mediated Facial Flushing (1989) (0)
Imaging Activation in the Migraine State (2012) (0)
Advances in Migraine Management, Vol. 34(suppl 2), 1994 (1994) (0)
Headache associated with prescription drugs (1998) (0)
Prospective recordings of the clinical presentation of migraine with typical aura (2013) (0)
INDOMETHACIN TEST USAGE AT UNITED KINGDOM TERTIARY CENTRES OVER 20 YEARS-AN AUDIT (2015) (0)
Trigeminal autonomic cephalgias I – cluster headache: diagnosis and treatment (2018) (0)
Patient-identified most bothersome symptom as a driver of health-related quality of life experienced by patients with migraine (P8-12.010) (2023) (0)
Evaluating migraine with typical aura with neuroimaging (2023) (0)
Reply (2004) (0)
To Our Reviewers (2004) (0)
EHMTI-0044. Variability of clinical features in attacks of migraine with aura (2014) (0)
Effect of Eptinezumab on Utility Scores in Patients with Migraine: Results from the DELIVER Study (P13-12.011) (2023) (0)
RAC-GWVI : Research Alerts — PubMed Citations for December 11 to 18 , 2018 1 GULF WAR ILLNESS The Relationship Between Traumatic Brain Injury and Rates of Chronic Symptomatic Illness in 202 Gulf War Veterans (2019) (0)
Headache associated with vascular disease: migraine and stroke (2018) (0)
18 IS MIGRAINE BAD FOR THE BRAIN? (2006) (0)
Total migraine freedom (TMF) for single pulse transcranial magnetic stimulation (sTMS) versus triptans for the early acute treatment of migraine (2013) (0)
Pathophysiology and Genetics of Migraine (2013) (0)
Positron emission tomography scan analysis of neuromodulation-controlled intractable chronic migraine headaches (2004) (0)
Principles of clinical neuro-epidemiology (2002) (0)
Intractable Headache Criteria: Reply (2007) (0)
PCR237 Effect of Eptinezumab on Utility Scores in Patients With Migraine: Results From the Deliver Study (2022) (0)
THUR 084 Cranial autonomic symptoms in cluster headache induced by nitroglycerin (2018) (0)
EHMTI-0024. The typical duration of migraine aura: a prospective diary-based study (2014) (0)
PCR4 Disease-Specific Quality-of-Life Measures Mapped to the EQ-5D in a Chronic Disorder With Recurrent Attacks: Analysis of the Deliver Trial in Patients With Migraine (2022) (0)
Letters to the editor (1995) (0)
Investigating the headache (2008) (0)
Transient Exacerbation Of Headache In Patients Receiving Intravenous Dihydroergotamine For Inpatient Management Of Chronic Migraine Does Not Alter Outcomes (P7.197) (2014) (0)
’ opinion about the primary headache diagnostic criteria of the ICHD-3 rd edition beta in children and adolescents (2017) (0)
Neurobiological Basis of Migraine (2019) (0)
Is Bariatric Surgery Associated with Spontaneous Intracranial Hypotension (2014) (0)
Mechanisms of memory and amnestic syndromes (2002) (0)
Headache associated with prescription drugs [monograph on CD-ROM] (1997) (0)
Vascular Theory of Migraine Debunked (2013) (0)
The TRPV-1 agonist olvanil inhibits nociceptive trigeminovascular activation in vivo in rat (2010) (0)
Windows on the working brain: functional imaging (2002) (0)
Disorders of vision (2002) (0)
01 Multi-Center 3T MRI Study of Thalamic Morpho - logy in Migraine using Label-Fusion-Based Segmentation and Deformation Based Morphometric Surface Analysis (0)
Headaches at altitude: Frequency, risk factors, and clinical features (2001) (0)
Author response to Dr. Gupta (2020) (0)
A Placebo-Controlled Study of Galcanezumab in Patients with Episodic Cluster Headache: Results from the 8-Week Double-Blind Treatment Phase (Plen02.004) (2019) (0)
Metabotropic Glutamate Receptor Antagonism Reduces Trigeminovascular Nociceptive Transmission (P1.295) (2015) (0)
Imaging Acute NeurologicDisease: Headache (2014) (0)
Editorial: Functional and Structural Brain Alterations in Headache: A Trait or a State? (2020) (0)
Medication overuse headache (2008) (0)
Effects of Intravenous Application of the Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonist Olcegepant on Trigeminothalamic Transmission (2010) (0)
PND99 The Humanistic Disease Burden of Episodic and Chronic Migraine in France, Spain and the United Kingdom (2020) (0)
Efficacy of Two Dose Regimens of Subcutaneous Fremanezumab Versus Placebo for the Preventive Treatment of Chronic Migraine (S32.005) (2018) (0)
Neuroimaging, Headache Disorders and (2014) (0)
6.16 – Migraine (2007) (0)
Clinical Characterization and Imaging of Triggered Attacks in Chronic Migraine and Posttraumatic Headache (2016) (0)
Impact of eptinezumab on work productivity beyond reductions in monthly migraine days: Post hoc analysis of the DELIVER trial (P13-12.012) (2023) (0)
S255 ASSESSING THE RISK OF THALAMIC POST‐STROKE PAIN BY MRI LESION MAPPING (2011) (0)
Impact of Eptinezumab Treatment on Migraine Frequency, Duration, and Severity in Patients with Migraine (659) (2020) (0)
NON-MIGRAINE RELATED PAIN BEHAVIOURS IN A TRANSGENIC "MIGRAINE MOUSE" WITH CIRCADIAN DISRUPTION (2017) (0)
Role of Monoclonal Antibodies against Calcitonin Gene-Related Peptide (CGRP) in Episodic Migraine Prevention: Where Do We Stand Today? (2021) (0)
Headache and sport (2020) (0)
Trigeminal Autonomic Cephalalgias: Diagnostic Dilemmas (2018) (0)
Onset of cluster headache (CH) triggered by emotional impact: a case report (2005) (0)
The Physiology of Migraine Aura (2011) (0)
Trigeminal Autonomic Cephalalgias (TACs) – Hemicrania Continua (2014) (0)
Migraine in women (2008) (0)
Alternative approaches where evidence is awaited or contested (2008) (0)
Genetics of Familial Hemiplegic Migraine (2007) (0)
Mild hyperphenylalaninemia (2020) (0)
Characterizing Prodrome (Premonitory Phase) in Migraine: Results From the PRODROME Trial Screening Period (S41.009) (2023) (0)
Cluster headache and paroxysmal hemicrania (2003) (0)
Atogepant for the preventive treatment of chronic migraine: results from the PROGRESS phase 3 trial (S47.005) (2023) (0)
To Our Reviewers (2007) (0)
The role of the specialist nurse in headache (2008) (0)
Perceptions, understandings and experiences of cluster headache patients in the north of England : a qualitative study (2015) (0)
Neurological manifestations of HTLV-I infection (2002) (0)
Hypnic headache - a "new type" of headache disorders (2002) (0)
PND121 - UTILITIES ASSOCIATED WITH ATTRIBUTES OF MIGRAINE PREVENTIVE TREATMENTS: ROUTE OF ADMINISTRATION AND ADVERSE EVENTS (2018) (0)
The diagnosis and management of multiple sclerosis (2002) (0)
Psychiatric side effects during methysergide treatment (Retracted article) (2005) (0)
Non-invasive vagus nerve stimulation for treatment of cluster headache: a retrospective review of prescribing in England (2021) (0)
Submission Transcranial Magnetic Stimulation for Migraine Prevention in Adolescents : A Pilot Open-Label Study (2018) (0)
Promoting recovery of neurological function (2002) (0)
Trigeminal Autonomic Cephalalgias: Treatment Options (2018) (0)
Triggers for Trigeminal Activation: Clinical Abstracts and Commentary (2005) (0)
Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab Versus Placebo for the Preventive Treatment of Episodic Migraine (P4.093) (2018) (0)
Treating Migraine in Children and Adolescents. (2020) (0)
Marco Polo of Australian neurology (2019) (0)
COMMENT Headache (2001) (0)
Toxic and metabolic neuropathies (2002) (0)
Myasthenia gravis and splenomegaly (1986) (0)
migraine Before the headache : Infant colic as an early life expression of (2012) (0)
Identifying Natural Subgroups of Migraine Based on Profiles of Comorbidities and Concomitant Conditions: Results of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study (P3.123) (2018) (0)
EHMTI-0045. The succession of aura and headache: a prospective diary-based study (2014) (0)
Cluster Headache: Acute and Transitional Treatment (2016) (0)
Interictal Resting-State Connectivity of the Insula Is Altered in Migraine Without Aura (S32.006) (2014) (0)
Bladder and sexual dysfunction (2002) (0)
The future of headache classification and classification research (2009) (0)
EHMTI-0046. The succession of aura symptoms: a prospective diary-based study (2014) (0)
Headache associated with nonvascuiar intracranial disorders (2018) (0)
Trigeminal Autonomic Cephalalgias (TACs) – Paroxysmal Hemicrania (2014) (0)
O012. Intra-variability of the characteristics of migraine attacks (2015) (0)
Cell birth and cell death in the central nervous system (2002) (0)
POH02 Impact of chronic vs episodic migraine on disability, health-related quality of life and healthcare resource utilisation in the UK (2010) (0)
Future Therapies for Trigeminal Autonomic Cephalalgias: Cluster Headache and Related Conditions (2019) (0)
Authors' reply (1996) (0)
CHRONIC DAILY HEADACHE ( SJ WANG (2013) (0)
Award Number: W81XWH-11-1-0647 TITLE: Novel Therapeutic Targets for Chronic Migraine PRINCIPAL INVESTIGATORS: Peter Goadsby CONTRACTING ORGANIZATION: University of California, San Francisco (2015) (0)
Low throughput preclinical models for headache (2008) (0)
Update on the Prophylaxis Update on the Prophylaxis (2008) (0)
Headache (2016) (0)
Behavioural manifestations of stroke (2002) (0)
Headache (chronic tension type). (2003) (0)
Correction: Hemicrania continua- building on experience and clinical science (2014) (0)
PO066 Alterations in attention, fatigue and alertness associated with the premonitory and postdrome stages of triggered migraine attacks (2017) (0)
IN64-FR-03 Brain imaging in primary headache (2009) (0)
Windows on the working brain: evoked potentials, magnetencephalography and depth recording (2002) (0)
Pathophysiology of Headache Progression (2015) (0)
31 IS THE MIGRAINOUS BRAIN NORMAL OUTSIDE OF ACUTE ATTACKS (2011) (0)
Authors’ reply to Litwin and Malhotra (2012) (0)
Is Botulinum Toxin Type A Effective for Headache Prophylaxis (2012) (0)
CHARACTERISATION OF THE PREMONITORY STAGE OF MIGRAINE IN PAEDIATRIC MIGRAINEURS (2016) (0)
Effectiveness and safety profile of greater occipital nerve blockade in cluster headache: a systematic review (2023) (0)
Novel Therapeutic Targets for Chronic Migraine (2014) (0)
Reply: Letters to the Editor (2004) (0)
Progressive cerebral degeneration of childhood (2002) (0)
Hypothalamic/pituitary function and dysfunction (2002) (0)
Restricted truncal sagittal movements of rapid eye movement behaviour disorder (2022) (0)
Sinus headache and nasal disease (2018) (0)
Octreotide dependency: a cautionary tale (2004) (0)
Herbal medicine (1996) (0)
Primary Cough Headache (2015) (0)
Two novel mutations in the CACNA1A gene leading to identical functional consequences but with different phenotypic expression. (2002) (0)
Disorders of mood (2002) (0)
Rizatriptanof its Efficacy in the Management of Migraine (1999) (0)
Co-Administration of the Permanently Charged Sodium Channel Blocker QX-314 and the TRPV-1 Agonist Capsaicin Inhibits Trigeminovascular Activation (2010) (0)
Migraine les neurones coupables (2003) (0)
The effect of hyper-buoyancy floatation (HBF), a model of simulated microgravity, on sleep and cognitive function in humans (2019) (0)
Neurostimulation and neuromodulation in headache disorders (2012) (0)
Effects of microiontophoresed calcitonin gene-related peptide (CGRP) and CGRP-antagonists on trigeminothalamic transmission (2010) (0)
PO070 Treatment effect in visual snow (2017) (0)
The treatment of acute ischemic stroke (2002) (0)
202 Placebo-controlled intravenous nitroglycerin phenotyping of acute attacks of cluster headache (2022) (0)
The development of headache services (2008) (0)
Can Imaging Change Migraine Treatment Paradigms (2012) (0)
Lorcaserin Safety in Overweight or Obese Patients. (2019) (0)
Syddansk Universitet Changes in Neurocognitive Architecture in Patients with Obstructive Sleep Apnea Treated with Continuous Positive Airway Pressure (2016) (0)
Classification and diagnosis of headache (2018) (0)
Metabolic Fatty Liver Disease (2009) (0)
Response to Dr Elliot Shevel’s comment on the Editorial ‘The trigeminovascular system does not require a peripheral sensory input to be activated—migraine is a central disorder’ (2012) (0)
Windows on the working brain: magnetic resonance spectroscopy (2002) (0)
Migraine: from pathophysiology to treatment. (2023) (0)
Headache Basic Anatomy and Physiology of the Trigeminovascular System (2003) (0)
Non-invasive neuromodulation of the cervical vagus nerve in rare primary headaches (2023) (0)
Cluster headache - the clinical picture: discussion summary (1999) (0)
The Premonitory Phase of Migraine (2017) (0)
Preventive management of stroke (2002) (0)
Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache (2022) (0)
Visual snow syndrome - a clinical and phenotypical description of over 1000 cases (411) (2020) (0)
A subclavian bruit in the thoracic outlet syndrome. (1989) (0)
MATTERS ARISING (1991) (0)
The brain and the cardiovascular system (2002) (0)
EHMTI-0125. Studying the permeability of the blood-brain barrier during migraine attacks using [11C]-dihydroergotamine (2014) (0)
Implementation and impact of headache guidelines (2010) (0)
The future of headache (2004) (0)
Role of Interventional Therapies for Migraine and Headache: Onabotulinum Toxin A, Stimulators, and Nerve Blocks (2019) (0)
The pathophysiology of primary headache (2018) (0)
Pathophysiology and Genetics of Trigeminal Autonomic Cephalalgias (2013) (0)
95. Pain, sensory system, and central effects: botulinum toxin and primary headache disorders (2015) (0)
Environmental toxins and neurological disease (2002) (0)
Managing external cold-stimulus headache with preventive naproxen (2020) (0)
P218 Prospective study of primary cough headache in a cough unit (2019) (0)
Dopamine receptors and the modulation of trigeminocervical complex (TCC) neurons in the rat (2006) (0)
Current Opinion in Neurology: Editorial introductions (2010) (0)
Treatment of migraine - Reply (2002) (0)
Nitroglycerine triggers triptan-responsive cranial allodynia and trigeminal neuronal hypersensitivity. (2019) (0)
Editorial introductions. (2020) (0)
Endogenous Opioids Mediate the sTMS Effects in the Sensory Thalamus of Migraine Models (2013) (0)
Headache due to disorders of CSF pressure (2008) (0)
Assessment of the patient with epilepsy (2002) (0)
From the Editor-in-Chief (2001) (0)
KCl-induced repetitive cortical spreading depression inhibiting trigeminal neuronal firing is mediated by 5-HT1B/1D and opioid receptors (2022) (0)
Olvanil Inhibits Trigeminal Activation through TRPV1 and CB1 Receptors in an In-Vivo Model Relevant to Migraine (2011) (0)
Safety and Tolerability of Rimegepant Every Other Day for Preventive Treatment of Migraine Plus As-Needed for Acute Treatment of Migraine: Results from A 52-Week, Open-Label Extension Phase (P12-12.006) (2023) (0)
"Increasing our understanding of migraine to enhance treatment outcomes"--symposium. Foreword. (2009) (0)
To Our Reviewers: In Praise of Headache: A Farewell to psalms (2008) (0)
Social Media Listening and Digital Profiling Study of People With Headache and Migraine: Retrospective Infodemiology Study. (2022) (0)
Occipital Headaches and Neuroimaging in Children (P4.324) (2014) (0)
Neurological manifestations of hematological diseases (2002) (0)
Principles of therapeutics (2002) (0)
The lack of Ambulation in REM sleep Behaviour disorder - Why do they stay in bed? (2022) (0)
Neurological complications of hepatic and gastrointestinal disease (2002) (0)
Nitroglycerine triggers triptan-responsive cranial allodynia and trigeminal neuronal hypersensitivity. (2019) (0)
Headache: Basic Anatomy and Physiology of the Trigeminovascular System (2003) (0)
update on a common neurological problem (2002) (0)
Characterization of trigeminal ganglion cell spontaneous calcium signalling and responses to ATP, PACAP and CGRP (2017) (0)
Migraine Therapy: Current Approaches and New Horizons (2018) (0)
To Our Reviewers (2002) (0)
Advances in the Treatment of Cluster Headache (2008) (0)
Comorbidity or combination – more evidence for cluster-migraine? (2023) (0)
Neuromodulatory Approaches to the Management of Medically Refractory Cluster Headache (2010) (0)
Diagnostic testing and ominous causes of headache (2018) (0)
Exploding head syndrome (a.k.a. episodic cranial sensory shock) responds to single‐pulse transcranial magnetic stimulation (2021) (0)
Proton magnetic resonance spectroscopy in migraine with persistent aura (2005) (0)
Migraine with Aura, Gene Polymorphisms, and Stroke Risk (2008) (0)
The clinical spectrum of epilepsy (2002) (0)
Referat – Vagusnerv-Stimulation bei akuten Migräneattacken (2015) (0)
Electronic Primary Care Records What Happens to New-Onset Headache Presented to Primary Care? A Case-Cohort Study Using (2010) (0)
Reply - Intractable headache criteria (2007) (0)
To Our Reviewers (2005) (0)
From the Editor-in-Chief (2000) (0)
Collagen–vascular disease and the nervous system (2002) (0)
PND54 Healthcare Resource Utilization and Economic Burden of Migraine in the United Kingdom, France, and Spain: Results of a Real-World Study (2020) (0)
Genotypes and Phenotypes Often Correlate in Familial Hemiplegic Migraine (2001) (0)
Medium-term real-world data for erenumab in 177 treatment resistant or difficult to treat chronic migraine patients: persistence and patient reported outcome measures after 17–30 months (2023) (0)
griffith . edu . au Enhancing cognitive-behavioural therapy for recurrent headache : Design of a randomised controlled trial (2017) (0)
Pathophysiology of metabolic myopathies (2002) (0)
Neurological complications after organ transplantation (2002) (0)
Nitroglycerine triggers triptan-responsive cranial allodynia and trigeminal neuronal hypersensitivity. (2019) (0)
Migraine a Disorder Involving Trigeminal Pathways Modulated by the Brainstem and Diencephalon (2020) (0)
Consciousness and its disorders (2002) (0)
Chronic daily headache: diagnosis and treatment (2018) (0)
Erratum: Afridi S. Evaluation and proposal for optimization of neurophysiological tests in migrane: Part 2-neuroimaging and the nitroglycerin test. (Cephalalgia (2007) 27 (1339-1359)) (2009) (0)
Severe headache of sudden onset (2008) (0)
PO067 Nitroglycerin triggering as a human migraine model in clinical research (2017) (0)
Book Review: Headache in Clinical Practice (1998) (0)
TRPV1 Receptors and Migraine (2010) (0)
Peripheral nociception and the genesis of persistent clinical pain (2002) (0)
Neurologic manifestations of endocrine disease (2002) (0)
EHMTI-0329. Cluster headaches - experience from a tertiary children's headache clinic (2014) (0)
Sarcoidosis of the nervous system (2002) (0)
Channel Contribution to Excitability Biophysical Characterization of Rat Caudal Hypothalamic Neurons: Calcium (2008) (0)
Pregnancy, breast-feeding and headache (2018) (0)
Physiology of the cerebral circulation (2002) (0)
Bench to bedside understanding of migraine pathophysiology (2021) (0)
migraine with visual aura Occipital activation in glyceryl trinitrate induced (2006) (0)
Headache associated with exertion, cough and sex (2008) (0)
The cellular basis of epilepsy (2002) (0)
Effects of eptinezumab on self-reported work productivity in adults with migraine and prior preventive treatment failure in the randomized, double-blind, placebo-controlled DELIVER study (2022) (0)
Renal disease and electrolyte disturbances (2002) (0)
Getting to grips with the basics (2008) (0)
A cell atlas for migraine research (2022) (0)

This paper list is powered by the following services:

Other Resources About Peter Goadsby

What Schools Are Affiliated With Peter Goadsby?

Peter Goadsby is affiliated with the following schools:

Peter Goadsby's Academic­Influence.com Rankings

Why Is Peter Goadsby Influential?

Peter Goadsby's Published Works

Published Works

Other Resources About Peter Goadsby

What Schools Are Affiliated With Peter Goadsby?

Peter Goadsby's AcademicInfluence.com Rankings